Publicaciones
2023
Pesántez, D, ten Hoorn, S, Machado, I, García-Albéniz, X, Rodríguez-Salas, N, Heredia-Soto, V, Viñal, D, Pericay, C, García-Carbonero, R, Losa, F, Alonso, V, Vera, R, Batlle, JF, Gallego, J, Salud, A, Nogué, M, Layos, L, Montagut, C, Capdevila, J, Vermeulen, L, Maurel, J, Fernandez-Martos, C (2023).
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 115(12):1497-1505.
[doi:10.1093/jnci/djad120]
Gonzalez, RS, Pastrián, LG, Pyatibrat, S, Arias HDQ, Gil, YR, Booth, AL, de la Peña Navarro I, Garmendia-Irizar, M, Lapointe, JR, Mobarki, M, Nova-Camacho, LM, Parini, G, Romio, E, Alayza, AR, Pritt, BS, Ruz-Caracuel, I (2023).
Submucosal Necrotic Nodule of the Colon.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. Article. 147(11):1315-1319.
[doi:10.5858/arpa.2022-0267-OA]
Delcuratolo, MD, Modrego-Sánchez, A, Bungaro, M, Antón-Pascual, B, Teran, S, Dipace, V, Novello, S, Garcia-Carbonero, R, Passiglia, F, Graválos-Castro, C (2023).
Liquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes
Journal Of Molecular Pathology. Review. 4(3):128-155.
[doi:10.3390/jmp4030013]
Castillón, JC, Gordoa, TA, Bayonas, AC, Carretero, AC, García-Carbonero, R, Pulido, EG, Fonseca, PJ, Lete, AL, Huerta, AS, Plazas, JG (2023).
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 25(9):2692-2706.
[doi:10.1007/s12094-023-03205-6]
Garcia-Carbonero, R, Astorga, BG, Tocino, RV, Toledo, DC, Pericay, C, Montes, AF, Falcó, E, Cordero, MG, Zoilo, JJR, Alonso, V, Salas, NR, Gil-Raga, M, Santos, C, Paez, D, Anton-Pascual, B, Aguilar, F, Morales, P (2023).
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY. Article.
[doi:10.1007/s12094-023-03309]
Garcia-Carbonero, R, Anton-Pascual, B, Modrego, A, Riesco-Martinez MDC, Lens-Pardo, A, Carretero-Puche, C, Rubio-Cuesta, B, Soldevilla, B (2023).
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: are we moving forward?
ENDOCRINE REVIEWS. Article. 44(4):724-736.
[doi:10.1210/endrev/bnad006]
Mitjavila, M, Jimenez-Fonseca, P, Belló, P, Pubul, V, Percovich, JC, Garcia-Burillo, A, Hernando, J, Arbizu, J, Rodeño, E, Estorch, M, Llana, B, Castellón, M, Garcia-Cañamaque, L, Gajate, P, Riesco, MC, Miguel, MB, Balaguer-Muñoz, D, Custodio, A, Cano, JM, Repetto, A, Garcia-Alonso, P, Muros, MA, Vercher-Conejero, JL, Carmona-Bayonas, A (2023).
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. Article. 50(8):2486-2500.
[doi:10.1007/s00259-023-06166-8]
Dasari, A, Lonardi, S, Garcia-Carbonero, R, Elez, E, Yoshino, T, Sobrero, A, Yao, JM, García-Alfonso, P, Kocsis, J, Gracian, AC, Sartore-Bianchi, A, Satoh, T, Randrian, V, Tomasek, J, Chong, GF, Paulson, AS, Masuishi, T, Jones, J, Csoszi, T, Cremolini, C, Ghiringhelli, F, Shergill, A, Hochster, HS, Krauss, J, Bassam, A, Ducreux, M, Elme, A, Faugeras, L, Kasper, S, Van Cutsem, E, Arnold, D, Nanda, S, Yang, Z, Schelman, WR, Kania, M, Tabernero, J, Eng, C (2023).
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
LANCET. Article. 402(10395):41-53.
[doi:10.1016/S0140-6736(23)00772-9]
Rinke, A, Ambrosini, V, Dromain, C, Garcia-Carbonero, R, Haji, A, Koumarianou, A, van Dijkum, EN, O'Toole, D, Rindi, G, Scoazec, JY, Ramage, J (2023).
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours
JOURNAL OF NEUROENDOCRINOLOGY. Article.
[doi:10.1111/jne.13309]
de Mestier, L, Resche-Rigon, M, Dromain, C, Lamarca, A, La Salvia, A, de Baker, L, Fehrenbach, U, Pusceddu, S, Colao, A, Borbath, I, de Haas, R, Rinzivillo, M, Zerbi, A, Funicelli, L, de Herder, WW, Selberherr, A, Wagner, AD, Manoharan, P, De Cima, A, Lybaert, W, Jann, H, Prinzi, N, Faggiano, A, Annet, L, Walenkamp, A, Panzuto, F, Pedicini, V, Pitoni, MG, Siebenhuener, A, Mayerhoefer, ME, Ruszniewski, P, Vullierme, MP (2023).
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST
JOURNAL OF NEUROENDOCRINOLOGY. Article.
[doi:10.1111/jne.13311]
Fazio, N, Gervaso, L, Halfdanarson, TR, Sonbol, M, Eiring, RA, Pusceddu, S, Prinzi, N, Lombardi Stocchetti, B, Grozinsky-Glasberg, S, Gross, DJ, Walter, T, Robelin, P, Lombard-Bohas, C, Frassoni, S, Bagnardi, V, Antonuzzo, L, Sparano, C, Massironi, S, Gelsomino, F, Bongiovanni, A, Ranallo, N, Tafuto, S, Rossi, M, Cives, M, Rasul Kakil, I, Hamid, H, Chirco, A, Squadroni, M, La Salvia, A, Hernando, J, Hofland, J, Koumarianou, A, Boselli, S, Tamayo, D, Mazzon, C, Rubino, M, Spada, F (2023).
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
ENDOCRINE-RELATED CANCER. Article. 30(6).
[doi:10.1530/ERC-22-0395]
Jiménez-Fonseca, P, Sastre, J, García-Alfonso, P, Gómez-España, MA, Salud, A, Gil, S, Rivera, F, Reina, JJ, Quintero, G, Valladares-Ayerbes, M, Safont, MJ, La Casta, A, Robles-Díaz, L, García-Paredes, B, López, RL, Guillot, M, Gallego, J, Alonso-Orduña, V, Diaz-Rubio, E, Aranda, E (2023).
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNu-1 and Phase II VISNu-2 Randomized Trials
Clinical Colorectal Cancer. Article. 22(2):222-230.
[doi:10.1016/j.clcc.2023.02.004]
Capdevila, J, Hernando, J, Teule, A, Lopez, C, Garcia-Carbonero, R, Benavent, M, Custodio, A, Garcia-Alvarez, A, Cubillo, A, Alonso, V, Carmona-Bayonas, A, Alonso-Gordoa, T, Crespo, G, Jimenez-Fonseca, P, Blanco, M, Viudez, A, La Casta, A, Sevilla, I, Segura, A, Llanos, M, Landolfi, S, Nuciforo, P, Manzano, JL (2023).
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
NATURE COMMUNICATIONS. Article. 14(1).
[doi:10.1038/s41467-023-38611-5]
Paredes-Ruiz, D, López-López, F, Núñez-Sobrino, JA, Gómez-Martin, C, Díaz-Pedroche, C, Lizasoain, M (2023).
Cytomegalovirus reactivation in patients with immune-mediated gastritis
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. Article. 41(5):298-300.
[doi:10.1016/j.eimc.2022.03.005]
Huebner, A, Black JRM, Sarno, F, Pazo, R, Juez, I, Medina, L, Garcia-Carbonero, R, Guillén, C, Feliú, J, Alonso, C, Arenillas, C, Moreno-Cárdenas, AB, Verdaguer, H, Macarulla, T, Hidalgo, M, McGranahan, N, Toledo, RA (2023).
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
GENOME MEDICINE. Article. 15(1):27-27.
[doi:10.1186/s13073-023-01171-w]
Soldevilla, B, Lens-Pardo, A, Espinosa-Olarte, P, Carretero-Puche, C, Molina-Pinelo, S, Robles, C, Benavent, M, Gomez-Izquierdo, L, Fierro-Fernández, M, Morales-Burgo, P, Jimenez-Fonseca, P, Anton-Pascual, B, Rodriguez-Gil, Y, Teijo-Quintans, A, La Salvia, A, Rubio-Cuesta, B, Riesco-Martínez, MC, Garcia-Carbonero, R (2023).
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
MOLECULAR ONCOLOGY. Article. 17(4):582-597.
[doi:10.1002/1878-0261.13393]
Ramadori, P, Woitok, MM, Estévez-Vázquez, O, Benedé-Ubieto, R, Leal-Lassalle, H, Lamas-Paz, A, Guo, FF, Fabre, J, Otto, J, Verwaayen, A, Reissing, J, Bruns, T, Erschfeld, S, Haas, U, Paffen, D, Nelson, LJ, Vaquero, J, Bañares, R, Trautwein, C, Cubero, FJ, Liedtke, C, Nevzorova, YA (2023).
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. Article. 1869(4).
[doi:10.1016/j.bbadis.2023.166646]
Yoshino T, Andre T, Kim TW, Yong WP, Shiu KK, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Alcaide-Garcia J, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Le DT, Adachi N, Fogelman D, Marinello P, Diaz LA Jr (2023).
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
CANCER SCIENCE. Article. 114(3):1026-1036.
[doi:10.1111/cas.15650]
Toledano-Fonseca, M, Gómez-España, MA, Élez, E, Grávalos, C, García-Alfonso, P, Rodríguez, R, Losa, F, Díaz, IA, Graña, B, Valladares-Ayerbes, M, García-Ortiz, MV, Polo, E, Salgado, M, Rivera, F, Safont, MJ, Salud, A, Ruiz-Casado, A, Tabernero, JM, Riesco, MC, Rodríguez-Ariza, A, Aranda, E (2023).
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
BIOMEDICINE & PHARMACOTHERAPY. Article. 159.
[doi:10.1016/j.biopha.2023.114272]
Nesti, C, Bräutigam, K, Benavent, M, Bernal, L, Boharoon, H, Botling, J, Bouroumeau, A, Brcic, I, Brunner, M, Cadiot, G, Camara, M, Christ, E, Clerici, T, Clift, AK, Clouston, H, Cobianchi, L, Cwikla, JB, Daskalakis, K, Frilling, A, Garcia-Carbonero, R, Grozinsky-Glasberg, S, Hernando, J, Hervieu, V, Hofland, J, Holmager, P, Inzani, F, Jann, H, Jimenez-Fonseca, P, Kaçmaz, E, Kaemmerer, D, Kaltsas, G, Klimacek, B, Knigge, U, Kolasinska-Cwikla, A, Kolb, W, Kos-Kudla, B, Kunze, CA, Landolfi, S, La Rosa, S, López, CL, Lorenz, K, Matter, M, Mazal, P, Mestre-Alagarda, C, del Burgo, PM, van Dijkum, EJMN, Oleinikov, K, Orci, LA, Panzuto, F, Pavel, M, Perrier, M, Reims, HM, Rindi, G, Rinke, A, Rinzivillo, M, Sagaert, X, Satiroglu, I, Selberherr, A, Siebenhüner, AR, Tesselaar, MET, Thalhammer, MJ, Thiis-Evensen, E, Toumpanakis, C, Vandamme, T, van den Berg, JG, Vanoli, A, van Velthuysen, MLF, Verslype, C, Vorburger, SA, Lugli, A, Ramage, J, Zwahlen, M, Perren, A, Kaderli, RM (2023).
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
LANCET ONCOLOGY. Article. 24(2):187-194.
[doi:10.1016/S1470-2045(22)00750-1]
Novillo, A, Gaibar, M, Romero-Lorca, A, Malón, D, Antón, B, Moreno, A, Fernández-Santander, A (2023).
HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
Cancers. Article. 15(3).
[doi:10.3390/cancers15030763]
Mayoral, IH, Santiago, AA, Sánchez-Zapardiel, JM, Calero, BH, de la Hoya, M, Gómez-Sanz, A, Reyes, MD, Robles, L (2023).
Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2
Genes. Article. 14(2).
[doi:10.3390/genes14020502]
Weir, A, Kang, EY, Meagher, NS, Nelson, GS, Ghatage, P, Lee, CH, Riggan, MJ, Gentry-Maharaj, A, Ryan, A, Singh, N, Widschwendter, M, Alsop, J, Anglesio, MS, Beckmann, MW, Berger, J, Bisinotto, C, Boros, J, Brand, AH, Brenton, JD, Brooks-Wilson, A, Carney, ME, Cunningham, JM, Cushing-Haugen, KL, Cybulski, C, Elishaev, E, Erber, R, Fereday, S, Fischer, A, Paz-Ares, L, Gayarre, J, Gilks, BC, Grube, M, Harnett, PR, Harris, HR, Hartmann, A, Hein, A, Hendley, J, Hernandez, BY, Heublein, S, Huang, YJ, Huzarski, T, Jakubowska, A, Jimenez-Linan, M, Kennedy, CJ, Kommoss, FKF, Koziak, JM, Kraemer, B, Le, ND, Lesnock, J, Lester, J, Lubinski, J, Menkiszak, J, Ney, B, Olawaiye, A, Orsulic, S, Osorio, A, Robles-Diaz, L, Ruebner, M, Shah, M, Sharma, R, Shvetsov, YB, Steed, H, Talhouk, A, Taylor, SE, Traficante, N, Vierkant, RA, Wang, C, Wilkens, LR, Winham, SJ, Benitez, J, Berchuck, A, Bowtell, DD, dos Reis, FJC, Cook, LS, DeFazio, A, Doherty, JA, Fasching, PA, Garcia, MJ, Goode, EL, Goodman, MT, Gronwald, J, Huntsman, DG, Karlan, BY, Kommoss, S, Modugno, F, Schildkraut, JM, Sinn, HP, Staebler, A, Kelemen, LE, Ford, CE, Menon, U, Pharoah, PDP, Kobel, M, Ramus, SJ, Bowtell, D, DeFazio, A, Traficante, N, Fereday, S, Brand, A, Harnett, P, Sharma, R (2023).
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
BRITISH JOURNAL OF CANCER. Article. 128(1):137-147.
[doi:10.1038/s41416-022-02014-y]
Vidal, J, Fernández-Rodríguez, MC, Casadevall, D, García-Alfonso, P, Páez, D, Guix, M, Alonso, V, Cano, MT, Santos, C, Durán, G, Elez, E, Manzano, JL, Garcia-Carbonero, R, Ferreiro, R, Losa, F, Pineda, E, Sastre, J, Rivera, F, Bellosillo, B, Tabernero, J, Aranda, E, Salazar, R, Montagut, C (2023).
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.
CLINICAL CANCER RESEARCH. Article. 29(2):379-388.
[doi:10.1158/1078-0432.CCR-22-1696]
Ferolla P, Berruti A, Spada F, Brizzi MP, Ibrahim T, Marconcini R, Giuffrida D, Amoroso V, La Salvia A, Vaccaro V, Faggiano A, Colao A, Volante M, Ghizzoni S, Mazzanti P, Houchard A, Fazio N (2023).
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study.
NEUROENDOCRINOLOGY. Article. 113(3):332-342.
[doi:10.1159/000526811]
2022
Carmona, V, Justo, I, Rodriguez-Gil, Y, Marcacuzco, A, Loinaz, C, Jimenez, C (2022).
Multicystic biliary hamartoma
CIRUGIA ESPANOLA. Letter. 100(12):800-802.
[doi:10.1016/j.cireng.2022.08.009]
Valladares-Ayerbes, M, Garcia-Alfonso, P, Luengo, JM, Caceres, PPP, Trujillo, OAC, Vidal-Tocino, R, Llanos, M, Ayala, BL, Miron, MLL, Salud, A, Nogueras, LC, Garcia-Carbonero, R, Safont, MJ, Ferrer, EF, Aparicio, J, Conesa, MAV, Guillen-Ponce, C, Garcia-Teijido, P, Magan, MBM, Busquier, I, Salgado, M, Vila, AL (2022).
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
Cancers. Article. 14(24).
[doi:10.3390/cancers14246075]
Hidalgo M, Garcia-Carbonero R, Lim KH, Messersmith WA, Garrido-Laguna I, Borazanci E, Lowy AM, Medina Rodriguez L, Laheru D, Salvador-Barbero B, Malumbres M, Shields DJ, Grossman JE, Huang X, Tammaro M, Martini JF, Yu Y, Kern K, Macarulla T (2022).
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.
Cancer Research Communications. Article. 2(11):1326-1333.
[doi:10.1158/2767-9764.CRC-22-0072]
Modica R, La Salvia A, Liccardi A, Cannavale G, Minotta R, Benevento E, Faggiano A, Colao A (2022).
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target.
Metabolites. Review. 12(11).
[doi:10.3390/metabo12111057]
de la Torre-Aláez M, Matilla A, Varela M, Iñarrairaegui M, Reig M, Lledó JL, Arenas JI, Lorente S, Testillano M, Márquez L, Da Fonseca L, Argemí J, Gómez-Martin C, Rodriguez-Fraile M, Bilbao JI, Sangro B (2022).
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study.
Journal For Immunotherapy Of Cancer. Article. 10(11).
[doi:10.1136/jitc-2022-005457]
Vera, R, Ibarrola-de-Andres, C, Adeva, J, Perez-Rojas, J, Garcia-Alfonso, P, Rodriguez-Gil, Y, Macarulla, T, Serrano-Pinol, T, Mondejar, R, Madrigal-Rubiales, B (2022).
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 24(11):2107-2119.
[doi:10.1007/s12094-022-02873-0]
Aparicio, J, Manrique, ACV, Capdevila, J, Boza, FM, Galvan, P, Richart, P, Oliveres, H, Paez, D, Hernando, J, Serrano, S, Vera, R, Hernandez-Yague, X, Gallego, RA, Riesco-Martinez, MC, de Albeniz, XG, Maurel, J (2022).
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 24(11):2155-2165.
[doi:10.1007/s12094-022-02868-x]
La Salvia A, Carletti R, Verrico M, Feola T, Puliani G, Bassi M, Sesti F, Pernazza A, Mazzilli R, Lamberti G, Siciliani A, Mancini M, Manai C, Venuta F, Ibrahim M, Tomao S, D'Amati G, Di Gioia C, Giannetta E, Cappuzzo F, Faggiano A (2022).
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.
Journal of Clinical Medicine. Article. 11(19).
[doi:10.3390/jcm11195958]
Riesco-Martinez MC, Modrego A, Espinosa-Olarte P, La Salvia A, Garcia-Carbonero R (2022).
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives.
CURRENT TREATMENT OPTIONS IN ONCOLOGY. Review. 23(9):1320-1337.
[doi:10.1007/s11864-022-01008-5]
Metovic J, La Salvia A, Rapa I, Napoli F, Birocco N, Pia Bizzi M, Garcia-Carbonero R, Ciuffreda L, Scagliotti G, Papotti M, Volante M (2022).
Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors.
ENDOCRINE PATHOLOGY. Article. 33(3):388-399.
[doi:10.1007/s12022-022-09722-4]
Fanciulli G, Modica R, La Salvia A, Campolo F, Florio T, Mikovic N, Plebani A, Di Vito V, Colao A, Faggiano A (2022).
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
Cancers. Review. 14(16).
[doi:10.3390/cancers14163991]
La Salvia A, Persano I, Parlagreco E, Audisio A, Cani M, Brizzi MP (2022).
Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.
MEDICAL ONCOLOGY. Review. 39(11):168-168.
[doi:10.1007/s12032-022-01764-2]
Lamberti G, La Salvia A (2022).
Neuroendocrine Tumors: Challenges and Future Perspectives.
Journal of Clinical Medicine. Editorial Material. 11(15).
[doi:10.3390/jcm11154351]
Zamponi V, La Salvia A, Tarsitano MG, Mikovic N, Rinzivillo M, Panzuto F, Giannetta E, Faggiano A, Mazzilli R (2022).
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function.
Journal of Clinical Medicine. Review. 11(14).
[doi:10.3390/jcm11143983]
Fernández-Gordón Sánchez FM, Gómez-Domínguez E, Paredes Ruiz D, Rodríguez Gil Y, Martín Algíbez A, Fernández Vázquez I, Martínez Montiel P (2022).
Ustekinumab for corticodependent immune-mediated colitis by pembrolizumab, an alternative for patients with concomitant liver injury.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. Letter. 114(6):356-357.
[doi:10.17235/reed.2022.8618/2022]
La Salvia A, Persano I, Siciliani A, Verrico M, Bassi M, Modica R, Audisio A, Zanata I, Trabalza Marinucci B, Trevisi E, Puliani G, Rinzivillo M, Parlagreco E, Baldelli R, Feola T, Sesti F, Razzore P, Mazzilli R, Mancini M, Panzuto F, Volante M, Giannetta E, Romero C, Appetecchia M, Isidori A, Venuta F, Ambrosio MR, Zatelli MC, Ibrahim M, Colao A, Brizzi MP, García-Carbonero R, Faggiano A (2022).
Prognostic significance of laterality in lung neuroendocrine tumors.
Endocrine. Article. 76(3):733-746.
[doi:10.1007/s12020-022-03015-w]
Borbath, I, Garcia-Carbonero, R, Bikmukhametov, D, Jimenez-Fonseca, P, Castaño A, Barkmanova, J, Sedlackova, E, Kollar, A, Christ, E, Kaltsas, G, Kos-Kudla, B, Maasberg, S, Verslype, C, Pape, UF (2022).
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.
EUROPEAN JOURNAL OF CANCER. Article. 168:80-90.
[doi:10.1016/j.ejca.2022.03.007]
Capdevila J, Ducreux M, García Carbonero R, Grande E, Halfdanarson T, Pavel M, Tafuto S, Welin S, Valentí V, Salazar R (2022).
Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors.
NEUROENDOCRINOLOGY. Review. 112(12):1155-1167.
[doi:10.1159/000524988]
Whisenant JG, Baena J, Cortellini A, Huang LC, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Métivier AC, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans AM, Wakelee H, Peters S, Horn L, Garassino MC, Torri V (2022).
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
JOURNAL OF THORACIC ONCOLOGY. Article. 17(5):661-674.
[doi:10.1016/j.jtho.2021.12.015]
Diaz LA Jr, Shiu, KK, Kim, TW, Jensen, BV, Jensen, LH, Punt, C, Smith, D, Garcia-Carbonero, R, Benavides, M, Gibbs, P, de la Fourchardiere, C, Rivera, F, Elez, E, Le, DT, Yoshino, T, Zhong, WY, Fogelman, D, Marinello, P, Andre, T (2022).
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
LANCET ONCOLOGY. Article. 23(5):659-670.
[doi:10.1016/S1470-2045(22)00197-8]
Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Klümpen HJ, Adeva J, Vogel A, Lleo A, Fabris L, Ponz-Sarvise M, Brustia R, Cardinale V, Braconi C, Vidili G, Jamieson NB, Macias RI, Jonas JP, Marzioni M, Holówko W, Folseraas T, Kupcinskas J, Sparchez Z, Krawczyk M, Krupa L, Scripcariu V, Grazi GL, Landa-Magdalena A, Ijzermans JN, Evert K, Erdmann JI, López-López F, Saborowski A, Scheiter A, Santos-Laso A, Carpino G, Andersen JB, Marin JJ, Alvaro D, Bujanda L, Forner A, Valle JW, Koerkamp BG, Banales JM (2022).
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
JOURNAL OF HEPATOLOGY. Article. 76(5):1109-1121.
[doi:10.1016/j.jhep.2021.12.010]
Benavides M, Gómez-España A, García-Alfonso P, González CG, Viéitez JM, Rivera F, Safont MJ, Abad A, Sastre J, Valladares-Ayerbes M, Carrato A, González-Flores E, Robles L, Salud A, Alonso-Orduña V, Montagut C, Asensio E, Díaz-Rubio E, Aranda E (2022).
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
EJSO. Article. 48(5):1123-1132.
[doi:10.1016/j.ejso.2021.11.122]
Capdevila, J, Grande, E, Garcia-Carbonero, R, Simo, M, del Olmo-Garcia, MI, Jimenez-Fonseca, P, Carmona-Bayonas, A, Pubul, V (2022).
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy
ONCOLOGIST. Article. 27(4):328-339.
[doi:10.1093/oncolo/oyab041]
Fernández-Montes A, Alcaide J, Alsina M, Custodio AB, Franco LF, Gallego Plazas J, Gómez-Martín C, Richart P, Rivera F, Martin-Richard M (2022).
SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021).
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 24(4):658-669.
[doi:10.1007/s12094-022-02801-2]
Koopman M, Pinto C, Bodoky G, Garcia-Carbonero R, Marti FM, Bachet JB (2022).
Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective.
FUTURE ONCOLOGY. Article. 18(11):1313-1320.
[doi:10.2217/fon-2021-1333]
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM (2022).
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 117:56-64.
[doi:10.1016/j.ijid.2022.01.040]
Elez, E, Gomez-Espana, MA, Gravalos, C, Garcia-Alfonso, P, Ortiz-Morales, MJ, Losa, F, Diaz, IA, Grana, B, Toledano-Fonseca, M, Valladares-Ayerbes, M, Polo, E, Salgado, M, De Castro, EM, Safont, MJ, Salud, A, Ruiz-Casado, A, Tabernero, J, Riesco, MD, Rodriguez-Ariza, A, Aranda, E (2022).
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
BRITISH JOURNAL OF CANCER. Article. 126(6):874-880.
[doi:10.1038/s41416-021-01638-w]
Garcia-Carbonero R, Bazan-Peregrino M, Gil-Martín M, Álvarez R, Macarulla T, Riesco-Martinez MC, Verdaguer H, Guillén-Ponce C, Farrera-Sal M, Moreno R, Mato-Berciano A, Maliandi MV, Torres-Manjon S, Costa M, Del Pozo N, Martínez de Villarreal J, Real FX, Vidal N, Capella G, Alemany R, Blasi E, Blasco C, Cascalló M, Salazar R (2022).
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Journal For Immunotherapy Of Cancer. Article. 10(3).
[doi:10.1136/jitc-2021-003255]
Borbath, I, Pape, UF, Deprez, PH, Bartsch, DK, Caplin, M, Falconi, M, Garcia-Carbonero, R, Grozinsky-Glasberg, S, Jensen, RT, Arnold, R, Ruszniewski, P, Toumpanakis, C, Valle, JW, O Toole D (2022).
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors.
JOURNAL OF NEUROENDOCRINOLOGY. Article. 34(3).
[doi:10.1111/jne.13105]
Rodriguez-Garzotto, A, Iglesias-Docampo, L, Diaz-Garcia, CV, Ruppen, I, Ximenez-Embun, P, Gomez, C, Rodriguez-Peralto, JL, de Frutos, JO, Lopez-Martin, JA, Gravalos, C, Cortes-Funes, H, Agullo-Ortuno, MT (2022).
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies
Therapeutic Advances in Medical Oncology. Article. 14.
[doi:10.1177/17588359221086911]
Shah, MNA, Udrea, AA, Bondarenko, I, Mansoor, W, Sanchez, RG, Sarosiek, T, Bozzarelli, S, Schenker, M, Gomez-Martin, C, Morgan, C, Oezgueroglu, M, Pikiel, J, Kalofonos, HP, Wojcik, E, Buchler, T, Swinson, D, Cicin, I, Joseph, M, Vynnychenko, I, Luft, AV, Enzinger, PC, Salek, T, Papandreou, C, Tournigand, C, Maiello, E, Wei, R, Ferry, D, Gao, L, Oliveira, JM, Ajani, JA (2022).
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies
Cancers. Article. 14(5).
[doi:10.3390/cancers14051168]
Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C, Sánchez-Guerrero Á, González-Olmedo J, López-López F, Bover-Larroya M, Yarza-Barrio R, Jara-Casas DD, Castelo-Laureiro A, Revilla-Ostolaza Y, Paz-Ares L, Lumbreras-Bermejo C, Díaz-Pedroche C (2022).
Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid
JOURNAL OF THROMBOSIS AND THROMBOLYSIS. Article. 53(2):1-8.
[doi:10.1007/s11239-021-02448-w]
Justo, I, Marcacuzco, A, Caso, O, Manrique, A, Garcia-Sesma, A, Calvo, J, Garcia-Conde, M, Fernandez, C, Del Pozo, P, Rodriguez, Y, Jimenez-Romero, C (2022).
New technique for abdominal wall procurement. Initial experience
CLINICAL TRANSPLANTATION. Article. 36(2).
[doi:10.1111/ctr.14535]
Fazio N, Gervaso L, Halfdanarson TR, La Salvia A, Hofland J, Hernando J, Sonbol MB, Garcia-Carbonero R, Capdevila J, de Herder WW, Koumarianou A, Kaltsas G, Rossi M, Grozinsky-Glasberg S, Oleinikov K, Boselli S, Tamayo D, Bagnardi V, Laffi A, Rubino M, Spada F (2022).
Corrigendum to 'Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study' [European Journal of Cancer 154 (2021) 246-252].
EUROPEAN JOURNAL OF CANCER. Correction. 160:289-290.
[doi:10.1016/j.ejca.2021.10.001]
Jimenez-Fonseca P, Carmona-Bayonas A, Lamarca A, Barriuso J, Castaño A, Benavent M, Alonso V, Riesco MDC, Alonso-Gordoa T, Custodio A, Sanchez Canovas M, Hernando J, López C, La Casta A, Fernandez Montes A, Marazuela M, Crespo G, Diaz JA, Feliciangeli E, Gallego J, Llanos M, Segura A, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle J, Garcia-Carbonero R (2022).
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study.
NEUROENDOCRINOLOGY. Article. 112(1):88-100.
[doi:10.1159/000514808]
2021
Fustero-Torre C, Jiménez-Santos MJ, García-Martín S, Carretero-Puche C, García-Jimeno L, Ivanchuk V, Di Domenico T, Gómez-López G, Al-Shahrour F (2021).
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
GENOME MEDICINE. Article. 13(1):187-187.
[doi:10.1186/s13073-021-01001-x]
Grande E, Rodriguez-Antona C, López C, Alonso-Gordoa T, Benavent M, Capdevila J, Teulé A, Custodio A, Sevilla I, Hernando J, Gajate P, Molina-Cerrillo J, Díez JJ, Santos M, Lanillos J, García-Carbonero R (2021).
SUNitinib and EVOfosfamide (TH-302) in systemic treatment-naïve patients with G1/G2 metastatic pancreatic neuroendocrine tumors, the GETNE-1408 trial.
ONCOLOGIST. Article. 26(11):941-949.
[doi:10.1002/onco.13885]
Bazan-Peregrino, M, Garcia-Carbonero, R, Laquente, B, Alvarez, R, Mato-Berciano, A, Gimenez-Alejandre, M, Morgado, S, Rodriguez-Garcia, A, Maliandi, MV, Riesco, MC, Moreno, R, Ginesta, MM, Perez-Carreras, M, Gornals, JB, Prados, S, Perea, S, Capella, G, Alemany, R, Salazar, R, Blasi, E, Blasco, C, Cascallo, M, Hidalgo, M (2021).
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
Journal For Immunotherapy Of Cancer. Article. 9(11).
[doi:10.1136/jitc-2021-003254]
Baudin, E, Caplin, M, Garcia-Carbonero, R, Fazio, N, Ferolla, P, Filosso, PL, Frilling, A, de Herder, WW, Horsch, D, Knigge, U, Korse, CM, Lim, E, Lombard-Bohas, C, Pavel, M, Scoazec, JY, Sundin, A, Berruti, A, ESMO Guidelines Comm (2021).
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 32, pg 439, 2021)
ANNALS OF ONCOLOGY. Correction. 32(11):1453-1455.
[doi:10.1016/j.annonc.2021.08.2150]
Zhu, AX, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DVT, Borad, MJ, Bridgewater, JA, Harris, WP, Murphy, AG, Oh, DY, Whisenant, JR, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Chamberlain, CX, Aguado-Fraile, E, Choe, S, Wu, B, Liu, H, Gliser, C, Pandya, SS, Valle, JW, Abou-Alfa, GK (2021).
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation The Phase 3 Randomized Clinical ClarIDHy Trial
JAMA oncology. Article. 7(11):1669-1677.
[doi:10.1001/jamaoncol.2021.3836]
La Salvia A, Sesti F, Grinzato C, Mazzilli R, Tarsitano MG, Giannetta E, Faggiano A (2021).
Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review.
Pharmaceuticals. Article. 14(10).
[doi:10.3390/ph14101039]
Valle, Juan W., Vogel, Arndt, Denlinger, Crystal S., He, Aiwu Ruth, Bai, Li-Yuan, Orlova, Rashida, Van Cutsem, Eric, Adeva, Jorge, Chen, Li-Tzong, Obermannova, Radka, Ettrich, Thomas J., Chen, Jen-Shi, Wasan, Harpreet, Girvan, Allicia C., Zhang, Wei, Liu, Jiangang, Tang, Chunlao, Ebert, Philip J., Aggarwal, Amit, McNeely, Samuel C., Moser, Brian A., Oliveira, Joana M., Carlesi, Roberto, Walgren, Richard A., Oh, Do-Youn (2021).
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
LANCET ONCOLOGY. Article. 22(10):1468-1482.
Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, Mitjavila-Casanovas M, Robledo M, Tena I, Alvarez-Escola C, Arístegui M, Bella-Cueto MR, Ferrer-Albiach C, Hanzu FA (2021).
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 23(10):1995-2019.
[doi:10.1007/s12094-021-02622-9]
Fazio N, Gervaso L, Halfdanarson TR, La Salvia A, Hofland J, Hernando J, Sonbol MB, Garcia-Carbonero R, Capdevila J, de Herder WW, Koumarianou A, Kaltsas G, Rossi M, Grozinsky-Glasberg S, Oleinikov K, Boselli S, Tamayo D, Bagnardi V, Laffi A, Rubino M, Spada F (2021).
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study.
EUROPEAN JOURNAL OF CANCER. Article. 154:246-252.
[doi:10.1016/j.ejca.2021.06.029]
Espinosa-Olarte, P, La Salvia, A, Riesco-Martinez, MC, Anton-Pascual, B, Garcia-Carbonero, R (2021).
Chemotherapy in NEN: still has a role?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. Review. 22(3):595-614.
[doi:10.1007/s11154-021-09638-0]
Figueiredo, J, Mercadillo, F, Melo, S, Barroso, A, Goncalves, M, Diaz-Tasende, J, Carneiro, P, Robles, L, Colina, F, Ibarrola, C, Perea, J, Morais-de-Sa, E, Seruca, R, Urioste, M (2021).
Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden
Cancers. Article. 13(17).
[doi:10.3390/cancers13174359]
Lamarca A, Santos-Laso A, Utpatel K, La Casta A, Stock S, Forner A, Adeva J, Folseraas T, Fabris L, Macias RIR, Krawczyk M, Krawczyk M, Cardinale V, Braconi C, Alvaro D, Evert M, Banales JM, Valle JW (2021).
REPLY.
HEPATOLOGY. Letter. 74(2):1129-1131.
[doi:10.1002/hep.31740]
La Salvia A, Portigliatti Pomeri A, Persano I, Trevisi E, Parlagreco E, Colombi N, Brizzi MP, Picci RL, Oliva F (2021).
Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review.
COMPREHENSIVE PSYCHIATRY. Article. 109:152244-152244.
[doi:10.1016/j.comppsych.2021.152244]
Auclin E, Vuagnat P, Smolenschi C, Taieb J, Adeva J, Nebot-Bral L, Garcia de Herreros M, Vidal Tocino R, Longo-Muñoz F, El Dakdouki Y, Martín-Romano P, Gaba L, Saurí T, Oliveres H, Castañón E, Garcia-Carbonero R, Besse B, Massard C, Mezquita L, Hollebecque A (2021).
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
Cancers. Article. 13(15).
[doi:10.3390/cancers13153776]
Giannetta E, La Salvia A, Rizza L, Muscogiuri G, Campione S, Pozza C, Colao AAL, Faggiano A (2021).
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Frontiers in Endocrinology. Review. 12:672499-672499.
[doi:10.3389/fendo.2021.672499]
Capdevila, J, Fazio, N, Lopez, C, Teule, A, Valle, JW, Tafuto, S, Custodio, A, Reed, N, Raderer, M, Grande, E, Garcia-Carbonero, R, Jimenez-Fonseca, P, Hernando, J, Bongiovanni, A, Spada, F, Alonso, V, Antonuzzo, L, Spallanzani, A, Berruti, A, La Casta, A, Sevilla, I, Kump, P, Giuffrida, D, Merino, X, Trejo, L, Gajate, P, Matos, I, Lamarca, A, Ibrahim, T (2021).
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
JOURNAL OF CLINICAL ONCOLOGY. Article. 39(20):2304-2304.
[doi:10.1200/JCO.20.03368]
Lamarca A, Santos-Laso A, Utpatel K, La Casta A, Stock S, Forner A, Adeva J, Folseraas T, Fabris L, Macias RIR, Krawczyk M, Krawczyk M, Cardinale V, Braconi C, Alvaro D, Evert M, Banales JM, Valle JW, Group: on behalf of the European Network for the Study of Cholangiocarcinoma (E (2021).
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
HEPATOLOGY. Article. 73(6):2311-2325.
[doi:10.1002/hep.31598]
Zou X, Koh GCC, Nanda AS, Degasperi A, Urgo K, Roumeliotis TI, Agu CA, Badja C, Momen S, Young J, Amarante TD, Side L, Brice G, Perez-Alonso V, Rueda D, Gomez C, Bushell W, Harris R, Choudhary JS, Jiricny J, Skarne WC, Nik-Zainal S, Genomics England Research Consortium (2021).
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage.
Nature Cancer. Article. 2(6):643-657.
[doi:10.1038/s43018-021-00200-0]
Soldevilla B, López-López A, Lens-Pardo A, Carretero-Puche C, Lopez-Gonzalvez A, La Salvia A, Gil-Calderon B, Riesco-Martinez MC, Espinosa-Olarte P, Sarmentero J, Rubio-Cuesta B, Rincón R, Barbas C, Garcia-Carbonero R (2021).
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance.
Cancers. Article. 13(11).
[doi:10.3390/cancers13112634]
Waddington KE, Robinson GA, Rubio-Cuesta B, Chrifi-Alaoui E, Andreone S, Poon KS, Ivanova I, Martin-Gutierrez L, Owen DM, Jury EC, Pineda-Torra I (2021).
LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Article. 118(21).
[doi:10.1073/pnas.2017394118]
Vidal J, Casadevall D, Bellosillo B, Pericay C, Garcia-Carbonero R, Losa F, Layos L, Alonso V, Capdevila J, Gallego J, Vera R, Salud A, Martin-Richard M, Nogué M, Cillán E, Maurel J, Faull I, Raymond V, Fernández-Martos C, Montagut C (2021).
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
CLINICAL CANCER RESEARCH. Article. 27(10):2890-2898.
[doi:10.1158/1078-0432.CCR-20-4769]
Justo I, Rodríguez-Gil Y, Villar R, Kadaoui SD, Rodríguez de la Calle J (2021).
Pancreas Sparing Duodenectomy for the Treatment of Mature Teratoma Infiltrating Duodenum.
CIRUGIA ESPANOLA. Case Reports. 99(5):392-394.
[doi:10.1016/j.ciresp.2020.05.016]
Tempero M, Oh DY, Tabernero J, Reni M, Van Cutsem E, Hendifar A, Waldschmidt DT, Starling N, Bachet JB, Chang HM, Maurel J, Garcia-Carbonero R, Lonardi S, Coussens LM, Fong L, Tsao LC, Cole G Jr, James D, Macarulla T (2021).
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study.
ANNALS OF ONCOLOGY. Article. 32(5):600-608.
[doi:10.1016/j.annonc.2021.01.070]
Andre T, Amonkar M, Norquist JM, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Sevilla I, De La Fouchardiere C, Rivera F, Elez E, Diaz LA Jr, Yoshino T, Van Cutsem E, Yang P, Farooqui M, Le DT (2021).
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
LANCET ONCOLOGY. Article. 22(5):665-677.
[doi:10.1016/S1470-2045(21)00064-4]
Gomez-Espana, MA, Montes, AF, Garcia-Carbonero, R, Mercade, TM, Maurel, J, Martin, AM, Pazo-Cid, R, Vera, R, Carrato, A, Feliu, J (2021).
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 23(5):988-1000.
[doi:10.1007/s12094-021-02573-1]
La Salvia A, Espinosa-Olarte P, Riesco-Martinez MDC, Anton-Pascual B, Garcia-Carbonero R (2021).
Targeted Cancer Therapy: What's New in the Field of Neuroendocrine Neoplasms?
Cancers. Review. 13(7).
[doi:10.3390/cancers13071701]
Santos, M, Lanillos, J, Roldan-Romero, JM, Caleiras, E, Montero-Conde, C, Cascon, A, Climent, MA, Anguera, G, Hernando, S, Lainez, N, Robledo, M, Robles, L, de Velasco, G, Garcia-Donas, J, Rodriguez-Antona, C (2021).
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma
GENETICS IN MEDICINE. Article. 23(4):698-704.
[doi:10.1038/s41436-020-01062-0]
Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso PL, Frilling A, de Herder WW, Hörsch D, Knigge U, Korse CM, Lim E, Lombard-Bohas C, Pavel M, Scoazec JY, Sundin A, Berruti A, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2021).
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(?).
ANNALS OF ONCOLOGY. Article. 32(4):439-451.
[doi:10.1016/j.annonc.2021.01.003]
Sastre J, García-Alfonso P, Viéitez JM, Cano MT, Rivera F, Reina-Zoilo JJ, Salud-Salvia A, Quintero G, Robles-Díaz L, Safont MJ, La Casta A, Gil S, Polo E, Asensio-Martínez E, García-Paredes B, López RL, Guillot M, Valladares-Ayerbes M, Aranda E, Díaz-Rubio E, Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) (2021).
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
Esmo Open. Article. 6(2):100062-100062.
[doi:10.1016/j.esmoop.2021.100062]
Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S (2021).
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches.
Journal of Clinical Medicine. Review. 10(7).
[doi:10.3390/jcm10071412]
Trilla-Fuertes L, Gámez-Pozo A, Maurel J, Garcia-Carbonero R, Capdevila J, G-Pastrián L, Mendiola M, Peña C, López-Vacas R, Cuatrecasas M, García-Alfonso P, Ramos-Ruiz R, Llorens C, Ghanem I, Conill C, Heredia-Soto V, Campos-Barros Á, Fresno Vara JÁ, Feliu J (2021).
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
SCIENTIFIC REPORTS. Article. 11(1):7402-7402.
[doi:10.1038/s41598-021-86966-w]
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Calle GM, Sánchez-Fernández M, Fernández-Ruiz M, Asín MAP, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, Juan RS, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM (2021).
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 105:319-325.
[doi:10.1016/j.ijid.2021.02.041]
Elez E, Ayala F, Felip E, García Campelo R, García Carbonero R, García Donás J, González Del Alba A, González Flores E, Hidalgo J, Isla D, Majem M, Rodríguez Lescure Á, Safont MJ, Santaballa A, Villacampa G, Vera R, Garrido P (2021).
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
Esmo Open. Article. 6(2):100048-100048.
[doi:10.1016/j.esmoop.2021.100048]
López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM, H12O Immunomodulation Therapy for COVID-19 Group (2021).
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 105:487-494.
[doi:10.1016/j.ijid.2021.02.099]
Tapial, S, Garcia, JL, Corchete, L, Holowatyj, AN, Perez, J, Rueda, D, Urioste, M, Gonzalez-Sarmiento, R, Perea, J (2021).
Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer
EUROPEAN JOURNAL OF HUMAN GENETICS. Article. 29(4):709-713.
[doi:10.1038/s41431-020-00774-w]
Prieto-García E, Díaz-García CV, Agudo-López A, Pardo-Marqués V, García-Consuegra I, Asensio-Peña S, Alonso-Riaño M, Pérez C, Gómez C, Adeva J, Paz-Ares L, López-Martín JA, Agulló-Ortuño MT (2021).
Tumor-Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread.
Biomedicines. Article. 9(4).
[doi:10.3390/biomedicines9040364]
Feliubadaló L, Moles-Fernández A, Santamariña-Pena M, Sánchez AT, López-Novo A, Porras LM, Blanco A, Capellá G, de la Hoya M, Molina IJ, Osorio A, Pineda M, Rueda D, de la Cruz X, Diez O, Ruiz-Ponte C, Gutiérrez-Enríquez S, Vega A, Lázaro C (2021).
A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients.
CLINICAL CHEMISTRY. Article. 67(3):518-533.
[doi:10.1093/clinchem/hvaa250]
Melisi D, Oh DY, Hollebecque A, Calvo E, Varghese A, Borazanci E, Macarulla T, Merz V, Zecchetto C, Zhao Y, Gueorguieva I, Man M, Gandhi L, Estrem ST, Benhadji KA, Lanasa MC, Avsar E, Guba SC, Garcia-Carbonero R (2021).
Safety and activity of the TGFß receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.
Journal For Immunotherapy Of Cancer. Article. 9(3).
[doi:10.1136/jitc-2020-002068]
Rodríguez Gil Y, Jiménez Sánchez P, Muñoz Velasco R, García García A, Sánchez-Arévalo Lobo VJ (2021).
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Review. 22(4).
[doi:10.3390/ijms22042077]
Giuppi M, La Salvia A, Evangelista J, Ghidini M (2021).
The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer.
BIOLOGY-BASEL. Review. 10(2).
[doi:10.3390/biology10020146]
Fernández-Ruiz M, López-Medrano F, Pérez-Jacoiste Asín MA, Maestro de la Calle G, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, San Juan R, Trujillo H, Lumbreras C, Aguado JM (2021).
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
JOURNAL OF MEDICAL VIROLOGY. Article. 93(2):831-842.
[doi:10.1002/jmv.26308]
Fazio, N, Gervaso, L, La Salvia, A, Hofland, J, Garcia-Carbonero, R, de Herder, WW, Boselli, S, Tamayo, D, Bagnardi, V, Spada, F (2021).
INTENSIVE (InterNaTional rEgistry oN Sars-cov-2 positiVe nEuroendocrine neoplasm patients)
JOURNAL OF NEUROENDOCRINOLOGY. Meeting Abstract. 33:51-51.
Perea, J, Garcia, JL, Corchete, L, Tapial, S, Olmedillas-Lopez, S, Vivas, A, Garcia-Olmo, D, Urioste, M, Goel, A, Gonzalez-Sarmiento, R (2021).
A clinico-pathological and molecular analysis reveals differences between solitary (early and late-onset) and synchronous rectal cancer
SCIENTIFIC REPORTS. Article. 11(1).
[doi:10.1038/s41598-020-79118-z]
Portigliatti Pomeri A, La Salvia A, Carletto S, Oliva F, Ostacoli L (2021).
EMDR in Cancer Patients: A Systematic Review.
FRONTIERS IN PSYCHOLOGY. Review. 11:590204-590204.
[doi:10.3389/fpsyg.2020.590204]
Viudez, A, Crespo, G, Gómez Dorronsoro ML, Arozarena, I, Marin-Mendez, JJ, Custodio, A, Benavent, M, Goñi S, Garcia-Paredes, B, Hern, J, Durantez, M, Alonso, V, Riesco MDC, Lopez, C, Jimenez-Fonseca, P, San Vicente, BL, Gonzalez-Borja, I, Sevilla, I, Hernandez-Garcia, I, Carmona-Bayonas, A, Capdevila, J, Perez-Sanz, J, Garcia-Carbonero, R, Perez-Ricarte, L, Llanos, M, Vera, R, De Jesús Acosta A (2021).
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
Pancreatology. Article. 21(1):215-223.
[doi:10.1016/j.pan.2020.12.009]
Marcacuzco Quinto AA, Nutu OA, Rodríguez Gil Y, Manrique A, Calvo Pulido J, García-Sesma Perez-Fuentes Á, Loinaz Segurola C, Jiménez Romero C, Justo Alonso I (2021).
Cystic liver neoplams: A single centre experience and literature review.
CIRUGIA ESPANOLA. Review. 99(1):27-33.
[doi:10.1016/j.ciresp.2020.04.007]
Navarro S, Cuatrecasas M, Hernández-Losa J, Landolfi S, Musulén E, Ramón Y Cajal S, García-Carbonero R, García-Foncillas J, Pérez-Segura P, Salazar R, Vera R, García-Alfonso P (2021).
Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia. Review. 54(1):41-54.
[doi:10.1016/j.patol.2020.07.004]
2020
Riesco-Martinez, MC, Fernandez-Martos, C, Gravalos-Castro, C, Espinosa-Olarte, P, La Salvia, A, Robles-Diaz, L, Modrego-Sanchez, A, Garcia-Carbonero, R (2020).
Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials.
Cancers. Review. 12(12).
[doi:10.3390/cancers12123655]
Andre, T, Shiu, KK, Kim, TW, Jensen, BV, Jensen, LH, Punt, C, Smith, D, Garcia-Carbonero, R, Benavides, M, Gibbs, P, de la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, DT, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, MZH, Marinello, P, Diaz, LA, KEYNOTE-177 Investigators (2020).
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
NEW ENGLAND JOURNAL OF MEDICINE. Article. 383(23):2207-2218.
[doi:10.1056/NEJMoa2017699]
Sanchez-Heras, AB, Castillejo, A, Garcia-Diaz, JD, Robledo, M, Teule, A, Sanchez, R, Zúñiga Á, Lastra, E, Duran, M, Llort, G, Yague, C, Ramon Y Cajal T, López San Martin C, Lopez-Fernandez, A, Balmaña J, Robles, L, Mesa-Latorre, JM, Chirivella, I, Fonfria, M, Perea Ibañez R, Castillejo, MI, Escandell, I, Gomez, L, Berbel, P, Soto, JL (2020).
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization.
Cancers. Article. 12(11).
[doi:10.3390/cancers12113277]
Muratori, L, Sperone, P, Gorzegno, G, La Salvia, A, Scagliotti, GV (2020).
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature.
Journal of the Egyptian National Cancer Institute. Review. 32(1):41-41.
[doi:10.1186/s43046-020-00052-2]
Cordero-Barreal, A, Caleiras, E, López de Maturana E, Monteagudo, M, Martinez-Montes, AM, Leton, R, Gil, E, Alvarez-Escola, C, Regojo, RM, Andia, V, Marazuela, M, Guadalix, S, Calatayud, M, Robles-Diaz, L, Aguirre, M, Cano, JM, Diaz, JA, Saavedra, P, Lamas, C, Azriel, S, Sastre, J, Aller, J, Leandro-Garcia, LJ, Calsina, B, Roldan-Romero, JM, Santos, M, Lanillos, J, Cascon, A, Rodriguez-Antona, C, Robledo, M, Montero-Conde, C (2020).
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Article. 105(11).
[doi:10.1210/clinem/dgaa527]
Aranda, E, Vieitez, JM, Gomez-Espana, A, Gil Calle S, Salud-Salvia, A, Graña B, Garcia-Alfonso, P, Rivera, F, Quintero-Aldana, GA, Reina-Zoilo, JJ, Gonzalez-Flores, E, Salgado Fernández M, Guillen-Ponce, C, Garcia-Carbonero, R, Safont, MJ, La Casta Munoa A, Garcia-Paredes, B, Lopez, RL, Sastre, J, Diaz-Rubio, E, Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) (2020).
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and =3 circulating tumour cells: the randomised phase III VISNÚ-1 trial.
Esmo Open. Article. 5(6).
[doi:10.1136/esmoopen-2020-000944]
Garcia-Alfonso, P, Garcia-Carbonero, R, Garcia-Foncillas, J, Perez-Segura, P, Salazar, R, Vera, R, Ramón Y Cajal S, Hernandez-Losa, J, Landolfi, S, Musulen, E, Cuatrecasas, M, Navarro, S (2020).
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 22(11):1976-1991.
[doi:10.1007/s12094-020-02357-z]
Spada, F, Pellicori, S, Zampino, G, Funicelli, L, Gervaso, L, Laffi, A, Rubino, M, Garcia-Carbonero, R, Fazio, N (2020).
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view.
Endocrine. Article. 70(1):6-10.
[doi:10.1007/s12020-020-02419-w]
Grande, E, Teule, A, Alonso-Gordoa, T, Jimenez-Fonseca, P, Benavent, M, Capdevila, J, Custodio, A, Vera, R, Munarriz, J, La Casta, A, Diez, JJ, Gajate, P, Molina-Cerrillo, J, Matos, I, Cristobal, EM, Ruffinelli, JC, Palacios, J, Garcia-Carbonero, R (2020).
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407).
ONCOLOGIST. Article. 25(9):745.
[doi:10.1634/theoncologist.2020-0033]
Martins, FC, Couturier, DL, Paterson, A, Karnezis, AN, Chow, C, Nazeran, TM, Odunsi, A, Gentry-Maharaj, A, Vrvilo, A, Hein, A, Talhouk, A, Osorio, A, Hartkopf, AD, Brooks-Wilson, A, DeFazio, A, Fischer, A, Hartmann, A, Hernandez, BY, McCauley, BM, Karpinskyj, C, de Sousa, CB, Høgdall C, Tiezzi, DG, Herpel, E, Taran, FA, Modugno, F, Keeney, G, Nelson, G, Steed, H, Song, HL, Luk, H, Benitez, J, Alsop, J, Koziak, JM, Lester, J, Rothstein, JH, de Andrade, JM, Lundvall, L, Paz-Ares, L, Robles-Diaz, L, Wilkens, LR, Garcia, MJ, Intermaggio, MP, Alcaraz, ML, Brett, MA, Beckmann, MW, Jimenez-Linan, M, Anglesio, M, Carney, ME, Schneider, M, Traficante, N, Pejovic, N, Singh, N, Le, N, Sinn, P, Ghatage, P, Erber, R, Edwards, R, Vierkant, R, Ness, RB, Leung, S, Orsulic, S, Brucker, SY, Kaufmann, SH, Fereday, S, Gayther, S, Winham, SJ, Kommoss, S, Pejovic, T, Longacre, TA, McGuire, V, Rhenius, V, Sieh, W, Shvetsov, YB, Whittemore, AS, Staebler, A, Karlan, BY, Rodriguez-Antona, C, Bowtell, DD, Goode, EL, Høgdall E, Candido Dos Reis FJ, Gronwald, J, Chang-Claude, J, Moysich, KB, Kelemen, LE, Cook, LS, Goodman, MT, Fasching, PA, Crawford, R, Deen, S, Menon, U, Huntsman, DG, Köbel M, Ramus, SJ, Pharoah PDP, Brenton, JD (2020).
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
BRITISH JOURNAL OF CANCER. Article. 123(5):793-802.
[doi:10.1038/s41416-020-0900-0]
Lopez-Lopez, A, Godzien, J, Soldevilla, B, Gradillas, A, Lopez-Gonzalvez, A, Lens-Pardo, A, La Salvia, A, Del Carmen Riesco-Martínez M, Garcia-Carbonero, R, Barbas, C (2020).
Oxidized lipids in the metabolic profiling of neuroendocrine tumors - Analytical challenges and biological implications.
JOURNAL OF CHROMATOGRAPHY A. Article. 1625:461233-461233.
[doi:10.1016/j.chroma.2020.461233]
Yarza, R, Bover, M, Paredes, D, Lopez-Lopez, F, Jara-Casas, D, Castelo-Loureiro, A, Baena, J, Mazarico, JM, Folgueira, MD, Melendez-Carmo, MA, Reyes, A, Lumbreras, C, Paz-Ares, L, Diaz-Pedroche, C, Gomez-Martin, C (2020).
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
EUROPEAN JOURNAL OF CANCER. Article. 135:242-250.
[doi:10.1016/j.ejca.2020.06.001]
Trevisi, E, La Salvia, A, Daniele, L, Brizzi, MP, De Rosa, G, Scagliotti, GV, Di Maio, M (2020).
Neuroendocrine breast carcinoma: a rare but challenging entity
MEDICAL ONCOLOGY. Review. 37(8).
[doi:10.1007/s12032-020-01396-4]
Trilla-Fuertes, L, Ghanem, I, Maurel, J, G-Pastrian, L, Mendiola, M, Peña C, Lopez-Vacas, R, Prado-Vazquez, G, Lopez-Camacho, E, Zapater-Moros, A, Heredia, V, Cuatrecasas, M, Garcia-Alfonso, P, Capdevila, J, Conill, C, Garcia-Carbonero, R, Heath, KE, Ramos-Ruiz, R, Llorens, C, Campos-Barros, A, Gamez-Pozo, A, Feliu, J, Vara JÁF (2020).
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma.
TRANSLATIONAL ONCOLOGY. Article. 13(7):100778-100778.
[doi:10.1016/j.tranon.2020.100778]
Garcia-Gonzalez, X, Kaczmarczyk, B, Abarca-Zabalia, J, Thomas, F, Garcia-Alfonso, P, Robles, L, Pachon, V, Vaz, A, Salvador-Martin, S, Sanjurjo-Saez, M, Lopez-Fernandez, LA (2020).
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine.
CANCER CHEMOTHERAPY AND PHARMACOLOGY. Article. 86(1):45-54.
[doi:10.1007/s00280-020-04093-1]
Abou-Alfa, GK, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DV, Borad, MJ, Bridgewater, J, Harris, WP, Murphy, AG, Oh, DY, Whisenant, J, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Fan, B, Wu, B, Chamberlain, CX, Jiang, LW, Gliser, C, Pandya, SS, Valle, JW, Zhu, AX (2020).
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
LANCET ONCOLOGY. Article. 21(6):796-807.
[doi:10.1016/S1470-2045(20)30157-1]
Carretero-Puche, C, Garcia-Martin, S, Garcia-Carbonero, R, Gomez-Lopez, G, Al-Shahrour, F (2020).
How can bioinformatics contribute to the routine application of personalized precision medicine?
Expert Review of Precision Medicine and Drug Development. Editorial Material. 5(3):115-117.
[doi:10.1080/23808993.2020.1758062]
Gonzalez-Acosta, M, Marin, F, Puliafito, B, Bonifaci, N, Fernandez, A, Navarro, M, Salvador, H, Balaguer, F, Iglesias, S, Velasco, A, Grau Garces E, Moreno, V, Gonzalez-Granado, LI, Guerra-Garcia, P, Ayala, R, Florkin, B, Kratz, C, Ripperger, T, Rosenbaum, T, Januszkiewicz-Lewandowska, D, Azizi, AA, Ragab, I, Nathrath, M, Pander, HJ, Lobitz, S, Suerink, M, Dahan, K, Imschweiler, T, Demirsoy, U, Brunet, J, Lazaro, C, Rueda, D, Wimmer, K, Capella, G, Pineda, M (2020).
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers.
JOURNAL OF MEDICAL GENETICS. Article. 57(4):269-273.
[doi:10.1136/jmedgenet-2019-106272]
Trilla-Fuertes, L, Ghanem, I, Gamez-Pozo, A, Maurel, J, G-Pastrian, L, Mendiola, M, Pena, C, Lopez-Vacas, R, Prado-Vazquez, G, Lopez-Camacho, E, Zapater-Moros, A, Heredia, V, Cuatrecasas, M, Garcia-Alfonso, P, Capdevila, J, Conill, C, Garcia-Carbonero, R, Ramos-Ruiz, R, Fortes, C, Llorens, C, Nanni, P, Fresno Vara JÁ, Feliu, J (2020).
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
MOLECULAR & CELLULAR PROTEOMICS. Article. 19(4):690-700.
[doi:10.1074/mcp.RA120.001954]
La Salvia, A, Persano, I, Trevisi, E, Parlagreco, E, Muratori, L, Scagliotti, GV, Brizzi, MP (2020).
Ocular metastases from neuroendocrine tumors: A literature review.
SEMINARS IN ONCOLOGY. Review. 47(2-3):144-147.
[doi:10.1053/j.seminoncol.2020.04.003]
Earl, J, Galindo-Pumarino, C, Encinas, J, Barreto, E, Castillo, ME, Pachon, V, Ferreiro, R, Rodriguez-Garrote, M, Gonzalez-Martinez, S, Cajal, TRY, Diaz, LR, Chirivella-Gonzalez, I, Rodriguez, M, de Castro, EM, Garcia-Seisdedos, D, Munoz, G, Rosa, JMR, Marquez, M, Malats, N, Carrato, A (2020).
A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants
EBioMedicine. Article. 53.
[doi:10.1016/j.ebiom.2020.102675]
Capdevila, J, Arques, O, Hernández Mora JR, Matito, J, Caratu, G, Mancuso, FM, Landolfi, S, Barriuso, J, Jimenez-Fonseca, P, Lopez, CL, Garcia-Carbonero, R, Hernando, J, Matos, I, Paolo, N, Hernandez-Losa, J, Esteller, M, Martinez-Cardus, A, Tabernero, J, Vivancos, A, Palmer, HG (2020).
Epigenetic EGFR gene repression confers sensitivity to therapeutic BRAFV600E blockade in colon neuroendocrine carcinomas.
CLINICAL CANCER RESEARCH. Article. 26(4):902-909.
[doi:10.1158/1078-0432.CCR-19-1266]
Lombardi, P, Marandino, L, De Luca, E, Zichi, C, Reale, ML, Pignataro, D, Di Stefano, RF, Ghisoni, E, Mariniello, A, Trevisi, E, Leone, G, Muratori, L, La Salvia, A, Sonetto, C, Leone, F, Aglietta, M, Novello, S, Scagliotti, GV, Perrone, F, Di Maio, M (2020).
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Review. 146.
[doi:10.1016/j.critrevonc.2020.102877]
Feliu, J, Garcia-Carbonero, R, Capdevila, J, Guasch, I, Alonso-Orduna, V, Lopez, C, Garcia-Alfonso, P, Castanon, C, Sevilla, I, Cerezo, L, Conill, C, Quintana-Angel, B, Sanchez, ME, Ghanem, I, Martin-Richard, M, Lopez-Gomez, M, Leon, A, Caro, M, Fernandez, T, Maurel, J (2020).
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).
Cancer Medicine. Article. 9(3):1008-1016.
[doi:10.1002/cam4.2722]
Guillen-Ponce, C, Lastra, E, Lorenzo-Lorenzo, I, Martín Gómez T, Morales Chamorro R, Sanchez-Heras, AB, Serrano, R, Soriano Rodríguez MC, Soto, JL, Robles, L (2020).
SEOM clinical guideline on hereditary colorectal cancer (2019).
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 22(2):201-212.
[doi:10.1007/s12094-019-02272-y]
Yoshino, T, Cleary, JM, Van Cutsem, E, Mayer, RJ, Ohtsu, A, Shinozaki, E, Falcone, A, Yamazaki, K, Nishina, T, Garcia-Carbonero, R, Komatsu, Y, Baba, H, Argiles, G, Tsuji, A, Sobrero, A, Yamaguchi, K, Peeters, M, Muro, K, Zaniboni, A, Sugimoto, N, Shimada, Y, Tsuji, Y, Hochster, HS, Moriwaki, T, Tran, B, Esaki, T, Hamada, C, Tanase, T, Benedetti, F, Makris, L, Yamashita, F, Lenz, HJ (2020).
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials.
ANNALS OF ONCOLOGY. Article. 31(1):88-95.
[doi:10.1016/j.annonc.2019.10.005]
Muratori, L, Pia, A, Reimondo, G, Pisano, C, La Salvia, A, Puglisi, S, Scagliotti, GV, Sperone, P (2020).
Prolonged Adrenal Insufficiency After Discontinuation Of Mitotane Therapy.
Endocrine Metabolic & Immune Disorders-Drug Targets. Article. 20(3):485-487.
[doi:10.2174/1871530319666190809144620]
Reale, ML, De Luca, E, Lombardi, P, Marandino, L, Zichi, C, Pignataro, D, Ghisoni, E, Di Stefano, RF, Mariniello, A, Trevisi, E, Leone, G, Muratori, L, La Salvia, A, Sonetto, C, Bironzo, P, Aglietta, M, Novello, S, Scagliotti, GV, Perrone, F, Di Maio, M (2020).
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
LUNG CANCER. Article. 139:47-54.
[doi:10.1016/j.lungcan.2019.10.022]
2019
Soldevilla, B, Carretero-Puche, C, Gomez-Lopez, G, Al-Shahrour, F, Riesco, MC, Gil-Calderon, B, Alvarez-Vallina, L, Espinosa-Olarte, P, Gomez-Esteves, G, Rubio-Cuesta, B, Sarmentero, J, La Salvia, A, Garcia-Carbonero, R (2019).
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
EUROPEAN JOURNAL OF CANCER. Article. 123:118-129.
[doi:10.1016/j.ejca.2019.09.008]
Suerink, M, Rodriguez-Girondo, M, van der Klift, HM, Colas, C, Brugieres, L, Lavoine, N, Jongmans, M, Munar, GC, Evans, DG, Farrell, MP, Genuardi, M, Goldberg, Y, Gomez-Garcia, E, Heinimann, K, Hoell, JI, Aretz, S, Jasperson, KW, Kedar, I, Modi, MB, Nikolaev, S, van Os, TAM, Ripperger, T, Rueda, D, Senter, L, Sjursen, W, Sunde, L, Therkildsen, C, Tibiletti, MG, Trainer, AH, Vos, YJ, Wagner, A, Winship, I, Wimmer, K, Zimmermann, SY, Vasen, HF, van Asperen, CJ, Houwing-Duistermaat, JJ, ten Broeke, SW, Nielsen, M (2019).
An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome
GENETICS IN MEDICINE. Article. 21(12):2706-2712.
[doi:10.1038/s41436-019-0577-z]
Garcia, JP, Arribas, J, Canete, A, Garcia, JL, Alvaro, E, Tapial, S, Narvaez, C, Vivas, A, Brandariz, L, Hernandez-Villafranca, S, Rueda, D, Rodriguez, Y, Perez-Garcia, J, Olmedillas-Lopez, S, Garcia-Olmo, D, Cavestro, GM, Urioste, M, Goel, A, Gonzalez-Sarmiento, R (2019).
Association of Polyps with Early-Onset Colorectal Cancer and Throughout Surveillance: Novel Clinical and Molecular Implications
Cancers. Article. 11(12).
[doi:10.3390/cancers11121900]
Fernandez-Martos, C, Pericay, C, Losa, F, Garcia-Carbonero, R, Layos, L, Rodriguez-Salas, N, Martin-Richard, M, Alonso-Orduna, V, Vera, R, Gallego, J, Capdevila, J, Salud, A, Nogue, M, Maurel, J, Guash, I, Montagut, C, Lopez, C, Macias, I, Jain, RK, Garcia-Albeniz, X (2019).
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
JAMA oncology. Article. 5(11):1566-1573.
[doi:10.1001/jamaoncol.2019.2294]
Wong WWL, Zargar, M, Berry, SR, Ko, YJ, Riesco-Martinez, M, Chan KKW (2019).
Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer.
Current Oncology. Article. 26(5):597-609.
[doi:10.3747/co.26.4843]
Garcia-Carbonero, R, Marquez-Rodas, I, de la Cruz-Merino, L, Martinez-Trufero, J, Cabrera, MA, Piulats, JM, Capdevila, J, Grande, E, Martin-Algarra, S, Berrocal, A (2019).
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
ONCOLOGIST. Article. 24(10):1375-1383.
[doi:10.1634/theoncologist.2018-0718]
Solis-Hernandez, MP, Fernandez Del Valle A, Carmona-Bayonas, A, Garcia-Carbonero, R, Custodio, A, Benavent, M, Alonso Gordoa T, Nuñez-Valdovino B, Sanchez Canovas M, Matos, I, Alonso, V, Lopez, C, Viudez, A, Izquierdo, M, Calvo-Temprano, D, Grande, E, Capdevila, J, Jimenez-Fonseca, P (2019).
Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study).
BRITISH JOURNAL OF CANCER. Article. 121(7):537-544.
[doi:10.1038/s41416-019-0558-7]
Carmona-Bayonas, A, Jimenez-Fonseca, P, Lamarca, A, Barriuso, J, Castaño Á, Benavent, M, Alonso, V, Riesco-Martínez MDC, Alonso-Gordoa, T, Custodio, A, Sánchez Cánovas M, Hernando Cubero J, Lopez, C, Lacasta, A, Fernández Montes A, Marazuela, M, Crespo, G, Escudero, P, Diaz, JA, Feliciangeli, E, Gallego, J, Llanos, M, Segura, A, Vilardell, F, Percovich, JC, Grande, E, Capdevila, J, Valle, JW, Garcia-Carbonero, R (2019).
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.
JOURNAL OF CLINICAL ONCOLOGY. Article. 37(28):2571-2580.
[doi:10.1200/JCO.19.00980]
Cardone, C, Martinelli, E, Troiani, T, Sforza, V, Avallone, A, Nappi, A, Montesarchio, V, Andreozzi, F, Biglietto, M, Calabrese, F, Bordonaro, R, Cordio, S, Bregni, G, Febbraro, AN, Garcia-Carbonero, R, Feliu, J, Cervantes, A, Ciardiello, F (2019).
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.
Esmo Open. Article. 4(4).
[doi:10.1136/esmoopen-2019-000519]
Neumann, HPH, Tsoy, U, Bancos, I, Amodru, V, Walz, MK, Tirosh, A, Kaur, RJ, McKenzie, T, Qi, XP, Bandgar, T, Petrov, R, Yukina, MY, Roslyakova, A, van der Horst-Schrivers, ANA, Berends, AMA, Hoff, AO, Castroneves, LA, Ferrara, AM, Rizzati, S, Mian, C, Dvorakova, S, Hasse-Lazar, K, Kvachenyuk, A, Peczkowska, M, Loli, P, Erenler, F, Krauss, T, Almeida, MQ, Liu, LF, Zhu, FZ, Recasens, M, Wohllk, N, Corssmit, EPM, Shafigullina, Z, Calissendorff, J, Grozinsky-Glasberg, S, Kunavisarut, T, Schalin-Jantti, C, Castinetti, F, Vlcek, P, Beltsevich, D, Egorov, VI, Schiavi, F, Links, TP, Lechan, RM, Bausch, B, Young, WF, Eng, C, Jaiswal, SK, Zschiedrich, S, Fragoso, MCBV, Pereira, MAA, Li, MH, Costa, JB, Juhlin, CC, Gross, D, Violante, AHD, Kocjan, T, Ngeow, J, Yoel, U, Fraenkel, M, Simsir, IY, Ugurlu, MU, Ziagaki, A, Diaz, LR, Kudlai, IS, Gimm, O, Scherbaum, CR, Abebe-Campino, G, Barbon, G, Taschin, E, Malinoc, A, Khudiakova, NV, Ivanov, NV, Pfeifer, M, Zovato, S, Ploeckinger, U, Makay, O, Grineva, E, Jarzab, B, Januszewicz, A, Shah, N, Seufert, J, Opocher, G, Larsson, C, Int Bilateral-Pheochromocytoma-Reg (2019).
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy
Jama Network Open. Article. 2(8).
[doi:10.1001/jamanetworkopen.2019.8898]
Tapial, S, Olmedillas-Lopez, S, Rueda, D, Arriba, M, Garcia, JL, Vivas, A, Perez, J, Pena-Couso, L, Olivera, R, Rodriguez, Y, Garcia-Arranz, M, Garcia-Olmo, D, Gonzalez-Sarmiento, R, Urioste, M, Goel, A, Perea, J (2019).
Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers.
SCIENTIFIC REPORTS. Article. 9(1):10516-10516.
[doi:10.1038/s41598-019-47014-w]
Lorca, V, Rueda, D, Martin-Morales, L, Fernandez-Acenero, MJ, Grolleman, J, Poves, C, Llovet, P, Tapial, S, Garcia-Barberan, V, Sanz, J, Perez-Segura, P, de Voer, RM, Diaz-Rubio, E, de la Hoya, M, Caldes, T, Garre, P (2019).
Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing.
SCIENTIFIC REPORTS. Article. 9(1):9814-9814.
[doi:10.1038/s41598-019-46403-5]
Salvador-Martiin, S, Garcia-Gonzalez, X, Garcia, MI, Blanco, C, Garcia-Alfonso, P, Robles, L, Gravalos, C, Pachon, V, Longo, F, Martinez, V, Sanjurjo-Saez, M, Lopez-Fernandez, LA (2019).
Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan".
PHARMACOLOGICAL RESEARCH. Letter. 145:104288-104288.
[doi:10.1016/j.phrs.2019.104288]
Muratori, L, La Salvia, A, Sperone, P, Di Maio, M (2019).
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Review. 139:41-52.
[doi:10.1016/j.critrevonc.2019.05.002]
Arriba, M, SANCHEZ GARCIA, CARMEN, Vivas, A, Nutu, OA, Rueda, D, Tapial, S, Rodriguez, Y, Brandariz, L, Garcia, JL, Garcia-Olmo, D, Goel, A, Gonzalez-Sarmiento, R, Urioste, M, Perea, J (2019).
Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer
PLOS ONE. Article. 14(5).
[doi:10.1371/journal.pone.0216472]
Gallon, R, Muhlegger, B, Wenzel, SS, Sheth, H, Hayes, C, Aretz, S, Dahan, K, Foulkes, W, Kratz, CP, Ripperger, T, Azizi, AA, Feldman, HB, Chong, AL, Demirsoy, U, Florkin, B, Imschweiler, T, Januszkiewicz-Lewandowska, D, Lobitz, S, Nathrath, M, Pander, HJ, Perez-Alonso, V, Perne, C, Ragab, I, Rosenbaum, T, Rueda, D, Seidel, MG, Suerink, M, Taeubner, J, Zimmermann, SY, Zschocke, J, Borthwick, GM, Burn, J, Jackson, MS, Santibanez-Koref, M, Wimmer, K (2019).
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes
HUMAN MUTATION. Article. 40(5):649-655.
[doi:10.1002/humu.23721]
Adeva, J, Sangro, B, Salati, M, Edeline, J, La Casta, A, Bittoni, A, Berardi, R, Bruix, J, Valle, JW (2019).
Medical treatment for cholangiocarcinoma
LIVER INTERNATIONAL. Review. 39:123-142.
[doi:10.1111/liv.14100]
Santos C, Azuara D, Vieitez JM, Paez D, Falco E, Elez E, Lopez-Lopez C, Valladares M, Robles-Diaz L, Garcia-Alfonso P, Buges C, Duran G, Salud A, Navarro V, Capella G, Salazar R, Aranda E (2019).
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
ANNALS OF ONCOLOGY. Article. 30(5):796-803.
[doi:10.1093/annonc/mdz082]
Melisi, D, Garcia-Carbonero, R, Macarulla, T, Pezet, D, Deplanque, G, Fuchs, M, Trojan, J, Kozloff, M, Simionato, F, Cleverly, A, Smith, C, Wang, S, Man, M, Driscoll, KE, Estrem, ST, Lahn MMF, Benhadji, KA, Tabernero, J (2019).
TGFbeta receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY. Article. 83(5):975-991.
[doi:10.1007/s00280-019-03807-4]
Perea, J, Garcia, JL, Corchete, L, Lumbreras, E, Arriba, M, Rueda, D, Tapial, S, Perez, J, Vieiro, V, Rodriguez, Y, Brandariz, L, Garcia-Arranz, M, Garcia-Olmo, D, Goel, A, Urioste, M, Sarmiento, RG (2019).
Redefining synchronous colorectal cancers based on tumor clonality
INTERNATIONAL JOURNAL OF CANCER. Article. 144(7):1596-1608.
[doi:10.1002/ijc.31761]
Vidal, J, Bellosillo, B, Santos Vivas C, Garcia-Alfonso, P, Carrato, A, Cano, MT, Garcia-Carbonero, R, Elez, E, Losa, F, Massuti, B, Valladares-Ayerbes, M, Vieitez, JM, Manzano, JL, Azuara, D, Gallego, J, Pairet, S, Capella, G, Salazar, R, Tabernero, J, Aranda, E, Montagut, C (2019).
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.
ANNALS OF ONCOLOGY. Article. 30(3):439-446.
[doi:10.1093/annonc/mdz005]
Grande, E, Diaz, A, Lopez, C, Munarriz, J, Reina, JJ, Vera, R, Bernardez, B, Aller, J, Capdevila, J, Garcia-Carbonero, R, Jimenez Fonseca P, Trapero-Bertran, M (2019).
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
Therapeutic Advances In Endocrinology And Metabolism. Review. 10.
[doi:10.1177/2042018819828217]
Alvaro, E, Cano, JM, Garcia, JL, Brandariz, L, Olmedillas-Lopez, S, Arriba, M, Rueda, D, Rodriguez, Y, Canete, A, Arribas, J, Inglada-Perez, L, Perez, J, Gomez, C, Garcia-Arranz, M, Garcia-Olmo, D, Goel, A, Urioste, M, Gonzalez-Sarmiento, R, Perea, J (2019).
Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-Onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Article. 20(4).
[doi:10.3390/ijms20040968]
Gonzalez-Granado, LI, Ruiz-Garcia, R, Blas-Espada, J, Moreno-Villares, JM, German-Diaz, M, Lopez-Nevado, M, Paz-Artal, E, Toldos, O, Rodriguez-Gil, Y, de Inocencio, J, Dominguez-Pinilla, N, Allende, LM (2019).
Acquired and Innate Immunity Impairment and Severe Disseminated Mycobacterium genavense Infection in a Patient With a NF-kappa B1 Deficiency
Frontiers in immunology. Article. 9:3148-3148.
[doi:10.3389/fimmu.2018.03148]
La Salvia, A, Lopez-Gomez, V, Garcia-Carbonero, R (2019).
HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
EXPERT OPINION ON INVESTIGATIONAL DRUGS. Article. 28(1):29-38.
[doi:10.1080/13543784.2019.1555583]
Baudin, E, Hayes, AR, Scoazec, JY, Filosso, PL, Lim, E, Kaltsas, G, Frilling, A, Chen, J, Kos-Kudla, B, Gorbunova, V, Wiedenmann, B, van Dijkum, EN, Cwikla, JB, Falkerby, J, Valle, JW, Kulke, MH, Caplin, ME, Detlef, B, Rudolf, A, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, Philippa, D, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, J, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Matthew, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Simon, RN, Guido, R, Anja, R, Philippe, R, Halfdan, S, Anders, S, Jean-Yves, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):7-17.
[doi:10.1159/000493980]
Ramage, JK, Valle, JW, Dijkum, EJMN, Sundin, A, Pascher, A, Couvelard, A, Kloeppel, G, Bartsch, D, Arnold, R, Baudin, E, Bodei, L, Borbath, I, Capdevila, J, Caplin, M, Chen, J, Costa, F, Couvelard, A, Cwikla, JB, Davies, P, de Herder, WW, Falconi, M, Falkerby, J, Fazio, N, Ferone, D, Frilling, A, Garcia-Carbonero, R, Glasberg, S, Gorbunova, V, Grossman, A, Horsch, D, Jensen, R, Kaltsas, G, Kloppel, G, Kingge, UP, Kos-Kudla, B, Krejs, GJ, Krenning, E, Kulke, M, Lamberts, SWJ, van Dijkum, EJMN, O'Connor, JM, O'Toole, D, Pape, UF, Partelli, S, Pavel, ME, Peeters, M, Ramage, JK, Reed, NS, Rindi, G, Rinke, A, Ruszniewski, P, Sorbye, H, Sundin, A, Scoazec, JY, Taal, BG, Janson, ET, Toumpanakis, C, Valle, JW, Vullierme, MP, Staffan, W, Wiedenmann, B, ENETS 2016 Munich Advisory Board (2019).
Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need
NEUROENDOCRINOLOGY. Article. 108(1):45-53.
[doi:10.1159/000493767]
Toumpanakis, C, Fazio, N, Janson, ET, Horsch, D, Pascher, A, Reed, N, O'Toole, D, Dijkum, EN, Partelli, S, Rinke, A, Kos-Kudla, B, Costa, F, Pape, UF, Grozinsky-Glasberg, S, Scoazec, JY, Detlef, B, Rudolf, A, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, J, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Matthew, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Nicholas, R, Guido, R, Anja, R, Philippe, R, Halfdan, S, Anders, S, Jean-Yves, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Needs in Appendiceal Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):37-44.
[doi:10.1159/000493894]
Jensen, RT, Bodei, L, Capdevila, J, Couvelard, A, Falconi, M, Glasberg, S, Kloppel, G, Lamberts, S, Peeters, M, Rindi, G, Rinke, A, Rothmund, M, Sundin, A, Welin, S, Fazio, N, Rudolf, A, Detlef, B, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, Philippa, D, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, TJ, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Simon, RN, Guido, R, Anja, R, Philippe, R, Jean-Yves, S, Halfdan, S, Anders, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):26-36.
[doi:10.1159/000494258]
Capdevila, J, Bodei, L, Davies, P, Gorbounova, V, Jensen, RT, Knigge, UP, Krejs, GJ, Krenning, E, O'Connor, JM, Peeters, M, Rindi, G, Salazar, R, Vullierme, MP, Pavel, ME, Arnold, R, Bartsch, D, Baudin, E, Bodei, L, Borbath, I, Capdevila, J, Caplin, M, Chen, J, Costa, F, Couvelard, A, Cwikla, JB, Davies, P, de Herder, WW, Falconi, M, Falkerby, J, Fazio, N, Ferone, D, Frilling, A, Garcia-Carbonero, R, Glasberg, S, Gorbunova, V, Grossman, A, Horsch, D, Jensen, RT, Kaltsas, G, Kloppel, G, Knigge, UP, Kos-Kudla, B, Krejs, GJ, Krenning, E, Kulke, M, Lamberts, SWJ, van Dijkum, EN, O'Connor, JM, O'Toole, D, Pape, UF, Partelli, S, Pavel, ME, Peeters, M, Ramage, J, Reed, NSB, Rindi, G, Rinke, A, Ruszniewski, P, Sorbye, H, Sundin, A, Scoazec, JY, Taal, BG, Tiensuu, JE, Toumpanakis, C, Valle, J, Vullierme, MP, Welin, S, Wiedenmann, B, ENETS 2016 Munich Advisory Board (2019).
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):18-25.
[doi:10.1159/000493319]
Jimenez-Fonseca, P, Alonso, V, Riesco, MC, Custodio, A, Molina-Cerrillo, J, Canovas, MS, Benavent, M, Cubero, JH, La Casta, A, Lopez, C, Azpiroz, MM, Carmona-Bayonas, A (2019).
Nomogram to Predict Progression-free Survival in Patients with Well-differentiated, Stage IV Gastroenteropancreatic Neuroendocrine Tumors Treated with Somatostatin Analogues: Data of TRASGU-GETNE Study
NEUROENDOCRINOLOGY. Meeting Abstract. 108:67-67.
Mitjavila, M, Percovich, JC, Pasin, MCP, Bello, P, Arbizu, J, Llana, B, Riesco, MC, Muros, MA, Estenoz, J, Rotger, A, Aller, J, Jimenez-Fonseca, P (2019).
Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry
NEUROENDOCRINOLOGY. Meeting Abstract. 108:223-223.
Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla JB, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R, ENETS 2016 Munich Advisory Board Participants (2019).
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
NEUROENDOCRINOLOGY. Article. 108(1):54-62.
[doi:10.1159/000493318]
Gonzalez-Flores E, Serrano R, Sevilla I, Viudez A, Barriuso J, Benavent M, Capdevila J, Jimenez-Fonseca P, Lopez C, Garcia-Carbonero R (2019).
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 21(1):55-63.
[doi:10.1007/s12094-018-1980-7]
Yoshino, T, Portnoy, DC, Obermannova, R, Bodoky, G, Prausova, J, Garcia-Carbonero, R, Ciuleanu, T, Garcia-Alfonso, P, Cohn, AL, Van Cutsem, E, Yamazaki, K, Lonardi, S, Muro, K, Kim, TW, Yamaguchi, K, Grothey, A, O'Connor, J, Taieb, J, Wijayawardana, SR, Hozak, RR, Nasroulah, F, Tabernero, J (2019).
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
ANNALS OF ONCOLOGY. Article. 30(1):124-131.
[doi:10.1093/annonc/mdy461]
Capdevila J, Teulé A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, García-Carbonero R, Dotor E, Matos I, Custodio A, Casanovas O, Salazar R, EVERLAR study investigators (2019).
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
ONCOLOGIST. Article. 24(1):38-46.
[doi:10.1634/theoncologist.2017-0622]
2018
Fernandez, A, Salgado, M, Garcia, A, Buxo, E, Vera, R, Adeva, J, Jimenez-Fonseca, P, Quintero, G, Llorca, C, Canabate, M, Lopez, LJ, Munoz, A, Ramirez, P, Gonzalez, P, Lopez, C, Reboredo, M, Gallardo, E, Sanchez-Canovas, M, Gallego, J, Guillen, C, Ruiz-Miravet, N, Navarro-Perez, V, De la Camara, J, Ales-Diaz, I, Pazo-Cid, RA, Carmona-Bayonas, A (2018).
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
BMC CANCER. Article. 18(1):1185-1185.
[doi:10.1186/s12885-018-5101-3]
Melisi, D, Garcia-Carbonero, R, Macarulla, T, Pezet, D, Deplanque, G, Fuchs, M, Trojan, J, Oettle, H, Kozloff, M, Cleverly, A, Smith, C, Estrem, ST, Gueorguieva, I, Lahn MMF, Blunt, A, Benhadji, KA, Tabernero, J (2018).
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
BRITISH JOURNAL OF CANCER. Article. 119(10):1208-1214.
[doi:10.1038/s41416-018-0246-z]
Marin-Gabriel, JC, Lora-Pablos, D, Diaz-Tasende, J, Cancelas-Navia, P, Rodriguez-Munoz, S, del-Pozo-Garcia, AJ, Alonso-Riano, M, Rodriguez-Gil, Y, Ibarrola-Andres, C, Castellano-Tortajada, G (2018).
Switching from endoscopic submucosal dissection to salvage piecemeal knife-assisted snare resection to remove a lesion: a preoperative risk score from the beginning
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. Article. 110(11):699-705.
[doi:10.17235/reed.2018.5608/2018]
Barriuso J, Custodio A, Afonso R, Alonso V, Astudillo A, Capdevila J, Garcia-Carbonero R, Grande E, Jimenez-Fonseca P, Marazuela M, Rodriguez-Antona C, Aller J (2018).
Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours
CANCER TREATMENT REVIEWS. Review. 70:209-222.
[doi:10.1016/j.ctrv.2018.09.008]
Damaso, E, Castillejo, A, Arias MDM, Canet-Hermida, J, Navarro, M, del Valle, J, Campos, O, Fernandez, A, Marin, F, Turchetti, D, Garcia-Diaz, JD, Lazaro, C, Genuardi, M, Rueda, D, Alonso, A, Soto, JL, Hitchins, M, Pineda, M, Capella, G (2018).
Primary constitutional MLH1 epimutations: a focal epigenetic event
BRITISH JOURNAL OF CANCER. Article. 119(8):978-987.
[doi:10.1038/s41416-018-0019-8]
Salvador-Martin, S, Garcia-Gonzalez, X, Garcia, MI, Blanco, C, Garcia-Alfonso, P, Robles, L, Gravalos, C, Pachon, V, Longo, F, Martinez, V, Sanjurjo-Saez, M, Lopez-Fernandez, LA (2018).
Clinical utility of ABCB1 for preventing toxicity in treatment with irinotecan
PHARMACOLOGICAL RESEARCH. Article. 136:133-139.
[doi:10.1016/j.phrs.2018.08.026]
Carril-Ajuria L, Jimenez-Aguilar E, Gomez-Martin C, Diaz-Pedroche C (2018).
An unsuspected complication with immune checkpoint blockade: a case report.
Journal Of Medical Case Reports. Article. 12(1):246-246.
[doi:10.1186/s13256-018-1782-0]
Krauss T, Ferrara AM, Links TP, Wellner U, Bancos I, Kvachenyuk A, Villar Gomez de Las Heras K, Yukina MY, Petrov R, Bullivant G, von Duecker L, Jadhav S, Ploeckinger U, Welin S, Schalin-Jantti C, Gimm O, Pfeifer M, Ngeow J, Hasse-Lazar K, Sanso G, Qi X, Ugurlu MU, Diaz RE, Wohllk N, Peczkowska M, Aberle J, Lourenco DM Jr, Pereira MAA, Fragoso MCBV, Hoff AO, Almeida MQ, Violante AHD, Quidute ARP, Zhang Z, Recasens M, Diaz LR, Kunavisarut T, Wannachalee T, Sirinvaravong S, Jonasch E, Grozinsky-Glasberg S, Fraenkel M, Beltsevich D, Egorov VI, Bausch D, Schott M, Tiling N, Pennelli G, Zschiedrich S, Darr R, Ruf J, Denecke T, Link KH, Zovato S, von Dobschuetz E, Yaremchuk S, Amthauer H, Makay O, Patocs A, Walz MK, Huber TB, Seufert J, Hellman P, Kim RH, Kuchinskaya E, Schiavi F, Malinoc A, Reisch N, Jarzab B, Barontini M, Januszewicz A, Shah N, Young WF Jr, Opocher G, Eng C, Neumann HPH, Bausch B (2018).
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors
ENDOCRINE-RELATED CANCER. Article. 25(9):783-793.
[doi:10.1530/ERC-18-0100]
Pena-Couso, L, Perea, J, Melo, S, Mercadillo, F, Figueiredo, J, Sanches, JM, Sanchez-Ruiz, A, Robles, L, Seruca, R, Urioste, M (2018).
Clinical and functional characterization of the CDH1 germline variant c.1679C > G in three unrelated families with hereditary diffuse gastric cancer
EUROPEAN JOURNAL OF HUMAN GENETICS. Article. 26(9):1348-1353.
[doi:10.1038/s41431-018-0173-8]
Diaz-Serrano, A, Angulo, B, Dominguez, C, Pazo-Cid, R, Salud, A, Jimenez-Fonseca, P, Leon, A, Galan, MC, Alsina, M, Rivera, F, Plaza, JC, Paz-Ares, L, Lopez-Rios, F, Gomez-Martin, C (2018).
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab
ONCOLOGIST. Article. 23(9):1092-1102.
[doi:10.1634/theoncologist.2017-0379]
Herrera, M, Llorens, C, Rodriguez, M, Herrera, A, Ramos, R, Gil, B, Candia, A, Larriba, MJ, Garre, P, Earl, J, Rodriguez-Garrote, M, Caldes, T, Bonilla, F, Carrato, A, Garcia-Barberan, V, Pena, C (2018).
Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
MOLECULAR CANCER. Article. 17(1):114-114.
[doi:10.1186/s12943-018-0863-4]
Tesch, VK, IJspeert, H, Raicht, A, Rueda, D, Dominguez-Pinilla, N, Allende, LM, Colas, C, Rosenbaum, T, Ilencikova, D, Baris, HN, Nathrath, MHM, Suerink, M, Januszkiewicz-Lewandowska, D, Ragab, I, Azizi, AA, Wenzel, SS, Zschocke, J, Schwinger, W, Kloor, M, Blattmann, C, Brugieres, L, van der Burg, M, Wimmer, K, Seidel, MG (2018).
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency
Frontiers in immunology. Article. 9:1506-1506.
[doi:10.3389/fimmu.2018.01506]
Salazar, R, Garcia-Carbonero, R, Libutti, SK, Hendifar, AE, Custodio, A, Guimbaud, R, Lombard-Bohas, C, Ricci, S, Klumpen, HJ, Capdevila, J, Reed, N, Walenkamp, A, Grande, E, Safina, S, Meyer, T, Kong, O, Salomon, H, Tavorath, R, Yao, JC (2018).
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naive Advanced Pancreatic Neuroendocrine Tumors
ONCOLOGIST. Article. 23(7):766.
[doi:10.1634/theoncologist.2017-0144]
Soriano-Ramos M, Salcedo Lobato E, Rodríguez Gil Y, Medina Benítez E, Urruzuno Tellería P (2018).
Hematemesis as debut of eosinophilic gastroenteritis in infants
ANALES DE PEDIATRIA. Letter. 88(6):351-353.
[doi:10.1016/j.anpedi.2017.09.003]
Martinez-Perez, J, Riesco-Martinez, MC, Garcia-Carbonero, R (2018).
The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
EXPERT OPINION ON DRUG SAFETY. Article. 17(6):643-650.
[doi:10.1080/14740338.2018.1475557]
Alvarez, R, Carrato, A, Adeva, J, Ales, I, Prados, S, Valladares, M, Macarulla, T, Munoz, A, Hidalgo, M (2018).
Management of hyperbilirubinaemia in pancreatic cancer patients
EUROPEAN JOURNAL OF CANCER. Review. 94:26-36.
[doi:10.1016/j.ejca.2018.01.078]
Cala, MP, Agullo-Ortuno, MT, Prieto-Garcia, E, Gonzalez-Riano, C, Parrilla-Rubio, L, Barbas, C, Diaz-Garcia, CV, Garcia, A, Pernaut, C, Adeva, J, Riesco, MC, Ruperez, FJ, Lopez-Martin, JA (2018).
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. Article. 9(2):348-357.
[doi:10.1002/jcsm.12270]
Nuñez-Valdovinos B, Carmona-Bayonas, A, Jimenez-Fonseca, P, Capdevila, J, Castaño-Pascual Á, Benavent, M, Pi Barrio JJ, Teule, A, Alonso, V, Custodio, A, Marazuela, M, Segura, A, Beguiristain, A, Llanos, M, Martinez Del Prado MP, Diaz-Perez, JA, Castellano, D, Sevilla, I, Lopez, C, Alonso, T, Garcia-Carbonero, R (2018).
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
ONCOLOGIST. Article. 23(4):422-432.
[doi:10.1634/theoncologist.2017-0364]
Brandariz L, Arriba M, García JL, Cano JM, Rueda D, Rubio E, Rodríguez Y, Pérez J, Vivas A, Sánchez C, Tapial S, Pena L, García-Arranz M, García-Olmo D, Urioste M, González-Sarmiento R, Perea J (2018).
Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location.
Oncotarget. Article. 9(20):15302-15311.
[doi:10.18632/oncotarget.24502]
Tabernero, J, Hozak, RR, Yoshino, T, Cohn, AL, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, TE, Portnoy, DC, Prausova, J, Muro, K, Siegel, RW, Konrad, RJ, Ouyang, H, Melemed, SA, Ferry, D, Nasroulah, F, Van Cutsem, E (2018).
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
ANNALS OF ONCOLOGY. Article. 29(3):602-609.
[doi:10.1093/annonc/mdx767]
Pavel, M, Gross, DJ, Benavent, M, Perros, P, Srirajaskanthan, R, Warner RRP, Kulke, MH, Anthony, LB, Kunz, PL, Hörsch D, Weickert, MO, Lapuerta, P, Jiang, WJ, Kassler-Taub, K, Wason, S, Fleming, R, Fleming, D, Garcia-Carbonero, R (2018).
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
ENDOCRINE-RELATED CANCER. Article. 25(3):309-322.
[doi:10.1530/ERC-17-0455]
Garrido, ML, Morago, AJ, Rovira, PS, Olarte, PE, Sanchez, CP, Sanchez, LM (2018).
Experience with eribulin in the treatment of elderly women with metastatic breast cancer:case studies
FUTURE ONCOLOGY. Article. 14(7):21-27.
[doi:10.2217/fon-2017-0357]
Tapial S, Rueda D, Arriba M, Luis Garcia J, Brandariz L, Perez J, Rodriguez Y, Garcia-Olmo D, Gonzalez-Sarmiento R, Urioste M, Perea J (2018).
Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system'
BRITISH JOURNAL OF CANCER. Letter. 118(3).
[doi:10.1038/bjc.2017.343]
Capdevila, J, Mancuso, F, Landolfi, S, Martinez-Cardus, A, Barriuso, J, Lopez, C, Grande, E, Miguel, C, Garcia-Carbonero, R, Hernando, J, Vivancos, A, Garcia-Palmer, H (2018).
BRAF-V600E Driven Mutations in Grade 3 Neuroendocrine Carcinomas of Colon Origin: Results from Genomic/Epigenomic Profilings and Patient-Derived Mouse Model
NEUROENDOCRINOLOGY. Meeting Abstract. 106:25-25.
Carmona-Bayonas, A, Jimenez-Fonseca, P, Castano, A, Capdevila, J, Benavent, M, Custodio, A, Alonso, V, Alonso, T, Del Olmo, MI, Peraita, SL, Teule, A, Garcia-Carbonero, R (2018).
Expanding the WHO 2017 Classification to Gastrointestinal Tumors: Real-World Data from the R-GETNE Registry
NEUROENDOCRINOLOGY. Meeting Abstract. 106:138-138.
Borbath, I, Pape, UF, Garcia-Carbonero, R, Sedlackova, E, Kollar, A, Kos-Kudla, B, Jimenez-Fonseca, P, Barkmanova, J, Maasberg, S, Bikmukhametov, D, Kaltsas, G, Verslype, C (2018).
The ENETS Registry: First Results of a Collaborative Effort Including over 12.000 Patients with Neuroendocrine Neoplasms (NENs) from 7 European Countries
NEUROENDOCRINOLOGY. Meeting Abstract. 106:62-62.
Jimenez-Fonseca, P, Hernandez, MPS, Del Valle, AF, Garcia-Carbonero, R, Matos, I, Alonso, V, Custodio, A, Alonso, T, Canovas, MS, Benavent, M, Lopez, C, Carmona-Bayonas, A (2018).
Efficacy of Sunitinib Correlated with Clinical, Radiological Variables, Dose-Intensity and Treatment Time in Advanced Grade 1-2 Pancreatic Neuroendocrine Tumors (CRIPNET-GETNE Study NCT02841865)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:214-214.
Bellido, F, Sowada, N, Mur, P, Lazaro, C, Pons, T, Valdes-Mas, R, Pineda, M, Aiza, G, Iglesias, S, Soto, JL, Urioste, M, Caldes, T, Balbin, M, Blay, P, Rueda, D, Duran, M, Valencia, A, Moreno, V, Brunet, J, Blanco, I, Navarro, M, Calin, GA, Borck, G, Puente, XS, Capella, G, Valle, L (2018).
Association Between Germline Mutations in &ITBRF1&IT, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer
GASTROENTEROLOGY. Article. 154(1):181.
[doi:10.1053/j.gastro.2017.09.005]
Siena, S, Sartore-Bianchi, A, Garcia-Carbonero, R, Karthaus, M, Smith, D, Tabernero, J, Van Cutsem, E, Guan, X, Boedigheimer, M, Ang, A, Twomey, B, Bach, BA, Jung, AS, Bardelli, A (2018).
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
ANNALS OF ONCOLOGY. Article. 29(1):119-126.
[doi:10.1093/annonc/mdx504]
Alonso, N, Cañueto J, Ciria, S, Bueno, E, Palacios-Alvarez, I, Alegre, M, Badenas, C, Barreiro, A, Pena, L, Maldonado, C, Nespeira-Jato, MV, Peña-Penabad C, Azon, A, Gavrilova, M, Ferrer, I, Sanmartin, O, Robles, L, Hernandez-Martin, A, Urioste, M, Puig, S, Puig, L, Gonzalez-Sarmiento, R (2018).
Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome
BRITISH JOURNAL OF DERMATOLOGY. Article. 178(1):198-206.
[doi:10.1111/bjd.15835]
Zugazagoitia, J, Rueda, D, Carrizo, N, Enguita, AB, Gomez-Sanchez, D, Diaz-Serrano, A, Jimenez, E, Merida, A, Calero, R, Lujan, R, De Miguel, E, Gamez, P, Diaz-Hellin, V, Nuñez JA, Iglesias, L, Ferrer, I, Paz-Ares, L, Ponce-Aix, S (2018).
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
CLINICAL LUNG CANCER. Article. 19(1):65.
[doi:10.1016/j.cllc.2017.06.008]
Carmona-Bayonas, A, del Valle, A, Solis, MP, Matos, I, Garcia-Carbonero, R, Alonso, V, Custodio, A, Alonso, T, Benavent, M, Viudez, A, Capdevila, J, Jimenez-Fonseca, P (2018).
Prognostic Impact of CHOI Response Criteria Compared to RECIST in Grade 1-2 Advanced Pancreatic Neuroendocrine Tumors (CRIPNET-GETNE Study-NCT02841865)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:169-169.
Hernando-Cubero, J, Manzano, JL, Benavent, M, Lopez, C, Teule, R, Garcia-Carbonero, R, Carmona-Bayonas, A, Crespo, G, Cubillo, A, Jimenez-Fonseca, P, LaCasta, A, Capdevila, J (2018).
Durvalumab plus Tremelimumab for the Treatment of Patients (pts) with Advanced Neuroendocrine Neoplasms (NENs) of Lung or Gastroenteropancreatic (GEP) Origin. A Phase II Multicohort Trial (DUNE Trial / GETNE 1601)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:228-228.
Tabernero, J, Hozak, RR, Yoshino, T, Cohn, AL, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, T, Portnoy, D, Muro, K, Ouyang, H, Melemed, SA, Ferry, D, Nasroulah, F, Cutsem, EV (2018).
Analysis of Angiogenesis Biomarkers for Ramucirumab (RAM) Efficacy in Patients with Metastatic Colorectal Cancer (mCRC) from RAISE, a Global, Randomized, Double-blind, Phase 3 Study
ONCOLOGY RESEARCH AND TREATMENT. Meeting Abstract. 41:55-55.
Portnoy, D, Obermannova, R, Bodoky, G, Prausova, J, Garcia-Carbonero, R, Ciuleanu, T, Alfonso, PG, Cohn, AL, Cutsem, EV, Yamazaki, K, Yoshino, T, Lonardi, S, Kim, TW, Yamaguchi, K, Grothey, A, O'Connor, J, Hsu, Y, Ferry, D, Nasroulah, F, Tabernero, J (2018).
Exploratory Analysis of Left Versus Right-sided colorectal Carcinoma in RAISE, a Randomized, Double-blind, Phase 3 Trial of Ramucirumab (RAM) plus FOLFIRI Versus Placebo (PBO) plus FOLFIRI
ONCOLOGY RESEARCH AND TREATMENT. Meeting Abstract. 41:54-54.
2017
Muñoz Martín AJ, Adeva J, Martínez-Galán J, Reina JJ, Hidalgo M (2017).
Pancreatic ductal adenocarcinoma: metastatic disease
CLINICAL & TRANSLATIONAL ONCOLOGY. Review. 19(12):1423-1429.
[doi:10.1007/s12094-017-1690-6]
Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, Chudecka-Glaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubinski J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Eilber U, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, deFazio A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido Dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ (2017).
Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and; Survival Time in High-Grade Serous Ovarian Cancer
JAMA oncology. Article. 3(12).
[doi:10.1001/jamaoncol.2017.3290]
Van Cutsem E, Falcone A, Garcia-Carbonero R, Komatsu Y, Pastorino A, Peeters M, Shimada Y, Yamazaki K, Yoshino T, Zaniboni A, Amellal N, Kanehisa A, Winkler R, Makris L, Mayer RJ, Ohtsu A, Tabernero J (2017).
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial.
Esmo Open. Article. 2(5).
[doi:10.1136/esmoopen-2017-000261]
Lorca V, Rueda D, Martín-Morales L, Poves C, Fernández-Aceñero MJ, Ruiz-Ponte C, Llovet P, Marrupe D, García-Barberán V, García-Paredes B, Pérez-Segura P, de la Hoya M, Díaz-Rubio E, Caldés T, Garre P (2017).
Role of GALNT12 in the genetic predisposition to attenuated adenomatous; polyposis syndrome
PLOS ONE. Article. 12(11).
[doi:10.1371/journal.pone.0187312]
Riesco-Martinez MC, Sanchez-Torre A, Garcia-Carbonero R (2017).
Safety and efficacy of nintedanib for the treatment of metastatic; colorectal cancer
EXPERT OPINION ON INVESTIGATIONAL DRUGS. Article. 26(11):1295-1305.
[doi:10.1080/13543784.2017.1385762]
Garcia-Carbonero R, Salazar R, Duran I, Osman-Garcia I, Paz-Ares L, Bozada JM, Boni V, Blanc C, Seymour L, Beadle J, Alvis S, Champion B, Calvo E, Fisher K (2017).
Phase 1 study of intravenous administration of the chimeric adenovirus; enadenotucirev in patients undergoing primary tumor resection
Journal For Immunotherapy Of Cancer. Article. 5(1):71-71.
[doi:10.1186/s40425-017-0277-7]
Carmona-Bayonas, A, Jimenez-Fonseca, P, Custodio, A, Grande, E, Capdevila, J, Lopez, C, Teule, A, Garcia-Carbonero, R, Spanish Neuroendocrine Tumor (2017).
Optimizing Somatostatin Analog Use in Well or Moderately Differentiated; Gastroenteropancreatic Neuroendocrine Tumors
Current Oncology Reports. Review. 19(11):72-72.
[doi:10.1007/s11912-017-0633-2]
Perez JM, Lopez-Calderero I, Saez C, Benavent M, Limon ML, Gonzalez-Exposito R, Soldevilla B, Riesco-Martinez MC, Salamanca J, Carnero A, Garcia-Carbonero R (2017).
Prognostic relevance of Src activation in stage II-III colon cancer
HUMAN PATHOLOGY. Article. 67:119-125.
[doi:10.1016/j.humpath.2017.05.025]
Cohn AL, Yoshino T, Heinemann V, Obermannova R, Bodoky G, Prausová J, Garcia-Carbonero R, Ciuleanu T, Garcia-Alfonso P, Portnoy DC, Van Cutsem E, Yamazaki K, Clingan PR, Polikoff J, Lonardi S, O'Brien LM, Gao L, Yang L, Ferry D, Nasroulah F, Tabernero J (2017).
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial
CANCER CHEMOTHERAPY AND PHARMACOLOGY. Article. 80(3):599-608.
[doi:10.1007/s00280-017-3380-z]
Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R (2017).
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in; Patient Selection for Clinical Benefit to Anti-EGFR Treatment in; Metastatic Colorectal Cancer
MOLECULAR CANCER THERAPEUTICS. Article. 16(9):1999-2007.
[doi:10.1158/1535-7163.MCT-17-0153]
Riesco-Martinez M, Parra K, Saluja R, Francia G, Emmenegger U (2017).
Resistance to metronomic chemotherapy and ways to overcome it
CANCER LETTERS. Review. 400:311-318.
[doi:10.1016/j.canlet.2017.02.027]
Pellicer M, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Rueda D, Martínez J, Pachón V, Longo F, Martínez V, Iglesias I, Salvador S, Sanjurjo M, López-Fernández LA (2017).
Use of exome sequencing to determine the full profile of genetic; variants in the fluoropyrimidine pathway in colorectal cancer patients; affected by severe toxicity
Pharmacogenomics. Article. 18(13):1215-1223.
[doi:10.2217/pgs-2017-0118]
Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M (2017).
Gastrointestinal complications induced by sevelamer crystals
CLINICAL KIDNEY JOURNAL. Article. 10(4):539-544.
[doi:10.1093/ckj/sfx013]
Custodio A, Carmona-Bayonas A, Jiménez-Fonseca P, Sánchez ML, Viudez A, Hernández R, Cano JM, Echavarria I, Pericay C, Mangas M, Visa L, Buxo E, García T, Rodríguez Palomo A, Álvarez Manceñido F, Lacalle A, Macias I, Azkarate A, Ramchandani A, Fernández Montes A, López C, Longo F, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Hurtado A, Madero R, Gómez C, Gallego J (2017).
Nomogram-based prediction of survival in patients with advanced; oesophagogastric adenocarcinoma receiving first-line chemotherapy: a; multicenter prospective study in the era of trastuzumab
BRITISH JOURNAL OF CANCER. Article. 116(12):1526-1535.
[doi:10.1038/bjc.2017.122]
Soldevilla B, CUEVAS MARTIN, MARIA DEL CARMEN, Ibáñez C, Santacatterina F, Alberti MA, Simó C, Casasnovas C, Márquez-Infante C, Sevilla T, Pascual SI, Sánchez-Aragó M, Espinos C, Palau F, Cuezva JM (2017).
Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients
PLOS ONE. Article. 12(6).
[doi:10.1371/journal.pone.0178376]
Hidalgo, M, Alvarez, R, Gallego, J, Guillen-Ponce, C, Laquente, B, Macarulla, T, Munoz, A, Salgado, M, Vera, R, Adeva, J, Ales, I, Arevalo, S, Blazquez, J, Calsina, A, Carmona, A, de Madaria, E, Diaz, R, Diez, L, Fernandez, T, de Paredes, BG, Gallardo, ME, Gonzalez, I, Hernando, O, Jimenez, P, Lopez, A, Lopez, C, Lopez-Rios, F, Martin, E, Martinez, J, Martinez, A, Montans, J, Pazo, R, Plaza, JC, Peiro, I, Reina, JJ, Sanjuanbenito, A, Yaya, R, Carrato, A (2017).
Consensus guidelines for diagnosis, treatment and follow-up of patients; with pancreatic cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 19(6):667-681.
[doi:10.1007/s12094-016-1594-x]
Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA (2017).
Identification of new SNPs associated with severe toxicity to; capecitabine
PHARMACOLOGICAL RESEARCH. Article. 120:133-137.
[doi:10.1016/j.phrs.2017.03.021]
Yoshino T, Obermannová R, Bodoky G, Garcia-Carbonero R, Ciuleanu T, Portnoy DC, Kim TW, Hsu Y, Ferry D, Nasroulah F, Tabernero J (2017).
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab; efficacy in RAISE, a second-line metastatic colorectal carcinoma phase; III trial
EUROPEAN JOURNAL OF CANCER. Article. 78:61-69.
[doi:10.1016/j.ejca.2017.03.007]
Lamarca A, Walter T, Pavel M, Borbath I, Freis P, Nuñez B, Childs A, McNamara MG, Hubner RA, Garcia-Carbonero R, Meyer T, Valle JW, Barriuso J (2017).
Design and Validation of the GI-NEC Score to Prognosticate Overall; Survival in Patients With High-Grade Gastrointestinal Neuroendocrine; Carcinomas
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 109(5).
[doi:10.1093/jnci/djw277]
Perea J, García JL, Pérez J, Rueda D, Arriba M, Rodríguez Y, Urioste M, González-Sarmiento R (2017).
NOMO-1 gene is deleted in early-onset colorectal cancer
Oncotarget. Article. 8(15):24429-24436.
[doi:10.18632/oncotarget.15478]
García-Ledo L, Nuevo-Tapioles C, CUEVAS MARTIN, MARIA DEL CARMEN, Martínez-Reyes I, Soldevilla B, González-Llorente L, Cuezva JM (2017).
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic; Phenotype in Breast Cancer
Frontiers in oncology. Article. 7:69-69.
[doi:10.3389/fonc.2017.00069]
Oberg K, Couvelard A, Delle Fave G, Gross D, Grossman A, Jensen RT, Pape UF, Perren A, Rindi G, Ruszniewski P, Scoazec JY, Welin S, Wiedenmann B, Ferone D, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
NEUROENDOCRINOLOGY. Article. 105(3):201-211.
[doi:10.1159/000472254]
Garcia-Carbonero R, Rinke A, Valle JW, Fazio N, Caplin M, Gorbounova V, O''Connor J, Eriksson B, Sorbye H, Kulke M, Chen J, Falkerby J, Costa F, de Herder W, Lombard-Bohas C, Pavel M, all other Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Neoplasms: Systemic Therapy - Chemotherapy
NEUROENDOCRINOLOGY. Article. 105(3):281-294.
[doi:10.1159/000473892]
García-Carbonero R, van Cutsem E, Rivera F, Jassem J, Gore I, Tebbutt N, Braiteh F, Argiles G, Wainberg ZA, Funke R, Anderson M, McCall B, Stroh M, Wakshull E, Hegde P, Ye W, Chen D, Chang I, Rhee I, Hurwitz H (2017).
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in; Combination with FOLFOX and Bevacizumab for First-Line Metastatic; Colorectal Cancer
ONCOLOGIST. Article. 22(4):375-30.
[doi:10.1634/theoncologist.2016-0133]
Salvador J, Aparicio J, Baron FJ, García-Campelo R, Garcia-Carbonero R, Lianes P, Llombart A, Isla D, Piera JM, Muñoz M, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P (2017).
Equity, barriers and cancer disparities: study of the Spanish Society of; Medical Oncology on the access to oncologic drugs in the Spanish Regions; (vol 19, pg 341, 2017)
CLINICAL & TRANSLATIONAL ONCOLOGY. Correction. 19(4):525-525.
[doi:10.1007/s12094-017-1628-z]
Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
NEUROENDOCRINOLOGY. Article. 105(3):212-244.
[doi:10.1159/000471879]
Perea J, Arriba M, Rodríguez Y, Rueda D, García JL, Pérez J, González-Sarmiento R, Urioste M (2017).
Frequency and impact of KRAS mutation in early onset colorectal cancer
HUMAN PATHOLOGY. Letter. 61:221-222.
[doi:10.1016/j.humpath.2016.07.039]
Michael M, Garcia-Carbonero R, Weber MM, Lombard-Bohas C, Toumpanakis C, Hicks RJ (2017).
The Antiproliferative Role of Lanreotide in Controlling Growth of; Neuroendocrine Tumors: A Systematic Review
ONCOLOGIST. Review. 22(3):272-285.
[doi:10.1634/theoncologist.2016-0305]
Arriba, Maria, Sanchez, Ricardo, Rueda, Daniel, Gomez, Laura, Garcia, Juan L., Rodriguez, Yolanda, Antonio Pajares, Jose, Perez, Jessica, Urioste, Miguel, Gonzalez Sarmiento, Rogelio, Perea, Jose (2017).
Toward a Molecular Classification of Synchronous Colorectal Cancer:; Clinical and Molecular Characterization
Clinical Colorectal Cancer. Article. 16(1):31-37.
[doi:10.1016/j.clcc.2016.07.014]
Pavel, Marianne, Gross, David, Benavent, Marta, Caplin, Martyn, Perros, Petros, Srirajaskanthan, Raj, Valle, Juan, Warner, Richard, Kulke, Matthew, Anthony, Lowell, Kunz, Pamela, Hoersch, Dieter, Oberg, Kjell, Lapuerta, Pablo, Jackson, Shanna, Banks, Phillip, Biran, Talia, Garcia-Carbonero, Rocio (2017).
Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial
Pancreas. Meeting Abstract. 46(3):434-435.
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, Nieveen van Dijkum EJM, Pape UF, Pascher A, Ramage J, Reed N, Ruszniewski P, Scoazec JY, Toumpanakis C, Kianmanesh R, Falconi M, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
NEUROENDOCRINOLOGY. Article. 105(3):255-265.
[doi:10.1159/000464292]
Knigge U, Capdevila J, Bartsch DK, Baudin E, Falkerby J, Kianmanesh R, Kos-Kudla B, Niederle B, Nieveen van Dijkum E, O'Toole D, Pascher A, Reed N, Sundin A, Vullierme MP, Antibes Consensus Conference Participants, Antibes Consensus Conference participants (2017).
ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation
NEUROENDOCRINOLOGY. Article. 105(3):310-319.
[doi:10.1159/000458155]
Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense RT, Kulke M, Oeberg K, Rindi G, Sorbye H, Welin S, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
NEUROENDOCRINOLOGY. Article. 105(3):196-200.
[doi:10.1159/000457956]
Garcia-Carbonero, R., Vera, R., Rivera, F., Parlorio, E., Pages, M., Gonzalez-Flores, E., Fernandez-Martos, C., Corral, M. A., Bouzas, R., Matute, F. (2017).
SEOM/SERAM consensus statement on radiological diagnosis, response; assessment and follow-up in colorectal cancer
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 19(2):135-148.
[doi:10.1007/s12094-016-1518-9]
Capdevila, J, Mancuso, F, Landolfi, S, Salva, F, Miguel, C, Jimenez-Fonseca, P, Garcia-Carbonero, R, Lopez, CL, Casteras, A, Nadal, TS, Nuciforo, P, Vivancos, A, Matos, I (2017).
Different RNA expression profile defines prognosis in grade 1/2; neuroendocrine neoplasms of small intestine origin: The GETNE-NETSEQ; study
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Lopez-Martin, JA, Cala, M, Prieto-Garcia, E, Riano, CG, Diaz-Garcia, CV, Garcia, A, Marques, VP, Pascualena, FR, Garcia-Ruiz, I, Pernaut, C, Otero, I, Rubio, LP, Riesco, MC, Alfonso, JA, Barbas, C, Agullo-Ortuno, MT (2017).
Metabolomics in cancer cachexia
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Pulido, EG, Teule, A, Alonso-Gordoa, T, Jimenez-Fonseca, P, Benavent, M, Capdevila, J, Custodio, A, Vera, R, Munarriz, J, La Casta-Munoa, A, Garcia-Carbonero, R (2017).
A phase II trial of palbociclib in metastatic grade 1/2 pancreatic; neuroendocrine tumors: The PALBONET study on behalf of the Spanish; Taskforce Group of Neuroendocrine Tumors (GETNE)
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Fernandez, A, Salgado, M, Garcia, A, Buxo, E, Vera, R, Adeva, J, Jimenez, P, Quintero, G, Llorca, C, Canabate, M, Lopez, LJ, Munoz, A, Ramirez, P, Gonzalez, P, Lopez, C, Reboredo, M, Gallardo, E, Sanchez, M, Gallego, J, Guillen, C (2017).
Treatment patterns, clinical characteristics, and outcomes of patients; (pts) with metastatic pancreatic cancer (MPC) treated with; nab-paclitaxel (nab-P) plus gemcitabine (GEM) in real-life practice:; ANICE-Pac trial
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
German-Diaz, M, Rodriguez-Gil, Y, Cruz-Rojo, J, Charbit-Henrion, F, Cerf-Bensussan, N, Manzanares-Lopez Manzanares, J, Moreno-Villares, JM (2017).
A New Case of Congenital Malabsorptive Diarrhea and Diabetes Secondary; to Mutant Neurogenin-3
PEDIATRICS. Article. 140(2).
[doi:10.1542/peds.2016-2210]
Barrios, MP, Martin, RL, Peerez, SP, Tamariz, VV, Yolanda, R, de Miguel, RA, Algarra, AC, de la Cruz, EG, Romero, PO, Peralto, JR (2017).
Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better; understand cancer
JOURNAL OF INVESTIGATIVE DERMATOLOGY. Meeting Abstract. 137(10):229-229.
[doi:10.1016/j.jid.2017.07.214]
Pavel, M, Valle, JW, Eriksson, B, Rinke, A, Caplin, M, Chen, J, Costa, F, Falkerby, J, Fazio, N, Gorbounova, V, de Herder, W, Kulke, M, Lombard-Bohas, C, O'Connor, J, Sorbye, H, Garcia-Carbonero, R, All Other Antibes Consensus Conf (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
NEUROENDOCRINOLOGY. Article. 105(3):266-280.
[doi:10.1159/000471880]
Kaltsas, G, Caplin, M, Davies, P, Ferone, D, Garcia-Carbonero, R, Grozinsky-Glasberg, S, Horsch, D, Janson, ET, Kianmanesh, R, Kos-Kudla, B, Pavel, M, Rinke, A, Falconi, M, de Herder, WW, All Other Antibes Consensus Conf (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine; Tumors
NEUROENDOCRINOLOGY. Article. 105(3):245-254.
[doi:10.1159/000461583]
Arriba, M, Garcia, JL, Rueda, D, Perez, J, Brandariz, L, Nutu, OA, Alonso, L, Rodriguez, Y, Urioste, M, Gonzalez-Sarmiento, R, Perea, J (2017).
Unsupervised Analysis of Array Comparative Genomic Hybridization Data; from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular; Classification and Phenotypes
NEOPLASIA. Article. 19(1):28-34.
[doi:10.1016/j.neo.2016.11.006]
Garcia-Carbonero, Rocio, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Jr., Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, Stroh, Mark, Wakshull, Eric, Hegde, Priti, Ye, Weilan, Chen, Daniel, Chang, Ilsung, Rhee, Ina, Hurwitz, Herbert (2017).
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer (vol 22, pg 375, 2017)
ONCOLOGIST. Correction. 22(10):1281-1281.
[doi:10.1634/theoncologist.2016-0133erratum]
De Mingo, ML, Guadalix, S, Alvarez, MBL, Herrero, EF, Diaz-Guerra, GM, Hawkins, F (2017).
Longer duration of TSH suppression can affect Bone Mineral Density and; Trabecular Bone Score in patients with Differentiated Thyroid Cancer.
JOURNAL OF BONE AND MINERAL RESEARCH. Meeting Abstract. 32:263-264.
Jiménez-Ubieto A, Rodriguez A, Martinez Sánchez P, Gómez A, Rodriguez Y, Carreño-Tarragona G, Martinez-López J, Grande C ().
Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE. Article.
[doi:10.1177/1078155217743069]
Lamarca A, Santos-Laso A, Utpatel K, La Casta A, Stock S, Forner A, Adeva J, Folseraas T, Fabris L, Macias RI, Krawczyk M, Krawczyk M, Cardinale V, Braconi C, Alvaro D, Evert M, Banales JM, Valle JW ().
Reply to (20-1119.R1) Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation.
HEPATOLOGY. Letter.
[doi:10.1002/hep.31904]
Olmedo Moreno C, Hernán Ocaña P, Rodríguez Gil Y, Díaz Tasende J ().
Gastric calcinosis ulcer in a renal transplanted patient.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. Article.
[doi:10.17235/reed.2023.9495/2023]
